UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q



☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended
	~~September~~June 30, ~~2019~~2020
	Or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-32410

CELANESE CORPORATION

(Exact Name of Registrant as Specified in its Charter)



Delaware	98-0420726
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

222 W. Las Colinas Blvd., Suite 900N

Irving, TX 75039-5421

(Address of Principal Executive Offices and zip code)

(972) 443-4000

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:



Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per share	CE	The New York Stock Exchange
1.125% Senior Notes due 2023	CE /23	The New York Stock Exchange
1.250% Senior Notes due 2025	CE /25	The New York Stock Exchange
2.125% Senior Notes due 2027	CE /27	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The number of outstanding shares of the registrant's common stock, $0.0001 par value, as of ~~October 15, 2019~~July 22, 2020 was ~~120,874,095.~~118,290,663.

CELANESE CORPORATION AND SUBSIDIARIES

Form 10-Q

For the Quarterly Period Ended ~~September~~June 30, ~~2019~~2020

TABLE OF CONTENTS



		Page
	PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements	3
	a) Unaudited Interim Consolidated Statements of Operations for the three and ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~2019	3
	b) Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) for the three and ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~2019	4
	c) Unaudited Consolidated Balance Sheets as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018~~2019	5
	d) Unaudited Interim Consolidated Statements of Equity for the three and ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~2019	6
	e) Unaudited Interim Consolidated Statements of Cash Flows for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~2019	8
	f) Notes to the Unaudited Interim Consolidated Financial Statements	9
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	4743
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	6158
Item 4.	Controls and Procedures	6258

	PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	6359
Item 1A.	Risk Factors	6359
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	6360
Item 3.	Defaults Upon Senior Securities	6361
Item 4.	Mine Safety Disclosures	6361
Item 5.	Other Information	6361
Item 6.	Exhibits	6462
Signatures		6563

Table of Contents

Item 1. Financial Statements

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018		2020		2019		2020		2019
	(In $ millions, except share and per share data)								(In $ millions, except share and per share data)
Net sales	1,586		1,771		4,865		5,466		1,193		1,592		2,653		3,279
Cost of sales	(1,172	)	(1,255	)	(3,575	)	(3,914	)	(951	)	(1,169	)	(2,063	)	(2,403	)
Gross profit	414		516		1,290		1,552		242		423		590		876
Selling, general and administrative expenses	(120	)	(129	)	(358	)	(412	)	(114	)	(118	)	(239	)	(238	)
Amortization of intangible assets	(6	)	(5	)	(18	)	(18	)	(6	)	(6	)	(11	)	(12	)
Research and development expenses	(17	)	(18	)	(50	)	(54	)	(18	)	(17	)	(35	)	(33	)
Other (charges) gains, net	(7	)	12		(101	)	9		(21	)	(98	)	(27	)	(94	)
Foreign exchange gain (loss), net	(1	)	—		5		2		1		1		—		6
Gain (loss) on disposition of businesses and assets, net	(3	)	(2	)	(2	)	(4	)	(1	)	1		(1	)	1
Operating profit (loss)	260		374		766		1,075		83		186		277		506
Equity in net earnings (loss) of affiliates	45		66		134		180		31		39		88		89
Non-operating pension and other postretirement employee benefit (expense) income	17		25		51		77		27		17		55		34
Interest expense	(27	)	(30	)	(87	)	(95	)	(27	)	(29	)	(55	)	(60	)
Refinancing expense	—		—		(4	)	—		—		(4	)	—		(4	)
Interest income	1		2		4		4		1		2		3		3
Dividend income - equity investments	27		26		89		92		32		30		69		62
Other income (expense), net	—		(1	)	(6	)	3		—		(2	)	2		(6	)
Earnings (loss) from continuing operations before tax	323		462		947		1,336		147		239		439		624
Income tax (provision) benefit	(53	)	(54	)	(127	)	(216	)	(35	)	(28	)	(100	)	(74	)
Earnings (loss) from continuing operations	270		408		820		1,120		112		211		339		550
Earnings (loss) from operation of discontinued operations	(6	)	(7	)	(9	)	(9	)	(4	)	(2	)	(11	)	(3	)
Income tax (provision) benefit from discontinued operations	1		1		2		1		1		1		1		1
Earnings (loss) from discontinued operations	(5	)	(6	)	(7	)	(8	)	(3	)	(1	)	(10	)	(2	)
Net earnings (loss)	265		402		813		1,112		109		210		329		548
Net (earnings) loss attributable to noncontrolling interests	(2	)	(1	)	(4	)	(4	)	(2	)	(1	)	(4	)	(2	)
Net earnings (loss) attributable to Celanese Corporation	263		401		809		1,108		107		209		325		546
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations	268		407		816		1,116		110		210		335		548
Earnings (loss) from discontinued operations	(5	)	(6	)	(7	)	(8	)	(3	)	(1	)	(10	)	(2	)
Net earnings (loss)	263		401		809		1,108		107		209		325		546
Earnings (loss) per common share - basic
Continuing operations	2.18		3.02		6.52		8.25		0.93		1.68		2.82		4.33
Discontinued operations	(0.04	)	(0.04	)	(0.06	)	(0.06	)	(0.03	)	(0.01	)	(0.08	)	(0.01	)
Net earnings (loss) - basic	2.14		2.98		6.46		8.19		0.90		1.67		2.74		4.32
Earnings (loss) per common share - diluted
Continuing operations	2.17		3.00		6.49		8.18		0.93		1.67		2.81		4.31
Discontinued operations	(0.04	)	(0.04	)	(0.06	)	(0.06	)	(0.03	)	(0.01	)	(0.09	)	(0.01	)
Net earnings (loss) - diluted	2.13		2.96		6.43		8.12		0.90		1.66		2.72		4.30
Weighted average shares - basic	122,699,859		134,519,301		125,159,647		135,336,704		118,339,872		125,289,967		118,795,780		126,409,926
Weighted average shares - diluted	123,299,664		135,499,390		125,868,829		136,387,703		118,767,633		125,847,894		119,377,515		127,111,046

See the accompanying notes to the unaudited interim consolidated financial statements.

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF

COMPREHENSIVE INCOME (LOSS)


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018		2020		2019		2020		2019
	(In $ millions)								(In $ millions)
Net earnings (loss)	265		402		813		1,112		109		210		329		548
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)	(7	)	(35	)	(11	)	(52	)	(6	)	(11	)	(8	)	(4	)
Gain (loss) on cash flow hedges	(32	)	4		(48	)	9		1		(13	)	(38	)	(16	)
Pension and postretirement benefits gain (loss)	—		—		—		1
Total other comprehensive income (loss), net of tax	(39	)	(31	)	(59	)	(42	)	(5	)	(24	)	(46	)	(20	)
Total comprehensive income (loss), net of tax	226		371		754		1,070		104		186		283		528
Comprehensive (income) loss attributable to noncontrolling interests	(2	)	(1	)	(4	)	(4	)	(2	)	(1	)	(4	)	(2	)
Comprehensive income (loss) attributable to Celanese Corporation	224		370		750		1,066		102		185		279		526

See the accompanying notes to the unaudited interim consolidated financial statements.

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED BALANCE SHEETS


	As of September 30, 2019		As of December 31, 2018		As of June 30, 2020		As of December 31, 2019
	(In $ millions, except share data)				(In $ millions, except share data)
ASSETS
Current Assets
Cash and cash equivalents (variable interest entity restricted - 2019: $46; 2018: $24)	497		439
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2019: $9; 2018: $10; variable interest entity restricted - 2019: $7; 2018: $6)	947		1,017
Cash and cash equivalents (variable interest entity restricted - 2020: $33; 2019: $57)					539		463
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2020: $10; 2019: $9; variable interest entity restricted - 2020: $5; 2019: $6)					729		850
Non-trade receivables, net	335		301		312		331
Inventories	994		1,046		1,031		1,038
Marketable securities, at fair value	26		31
Marketable securities					36		40
Other assets	44		40		62		43
Total current assets	2,843		2,874		2,709		2,765
Investments in affiliates	970		979		957		975
Property, plant and equipment (net of accumulated depreciation - 2019: $2,848; 2018: $2,803; variable interest entity restricted - 2019: $631; 2018: $659)	3,585		3,719
Property, plant and equipment (net of accumulated depreciation - 2020: $3,087; 2019: $2,957; variable interest entity restricted - 2020: $612; 2019: $622)					3,725		3,713
Operating lease right-of-use assets	206		—		201		203
Deferred income taxes	98		84		100		96
Other assets (variable interest entity restricted - 2019: $2; 2018: $5)	344		290
Other assets (variable interest entity restricted - 2020: $15; 2019: $9)					399		338
Goodwill	1,054		1,057		1,098		1,074
Intangible assets (variable interest entity restricted - 2019: $22; 2018: $23)	314		310
Intangible assets (variable interest entity restricted - 2020: $22; 2019: $22)					317		312
Total assets	9,414		9,313		9,506		9,476
LIABILITIES AND EQUITY
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	368		561		1,045		496
Trade payables - third party and affiliates	764		819		599		780
Other liabilities	358		343		572		461
Income taxes payable	43		56		46		17
Total current liabilities	1,533		1,779		2,262		1,754
Long-term debt, net of unamortized deferred financing costs	3,359		2,970		2,989		3,409
Deferred income taxes	269		255		256		257
Uncertain tax positions	169		158		189		165
Benefit obligations	523		564		579		589
Operating lease liabilities	182		—		183		181
Other liabilities	240		208		179		223
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2019 and 2018: 0 issued and outstanding)	—		—
Common stock, $0.0001 par value, 400,000,000 shares authorized (2019: 168,948,063 issued and 121,333,303 outstanding; 2018: 168,418,954 issued and 128,095,849 outstanding)	—		—
Treasury stock, at cost (2019: 47,614,760 shares; 2018: 40,323,105 shares)	(3,622	)	(2,849	)
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2020 and 2019: 0 issued and outstanding)					—		—
Common stock, $0.0001 par value, 400,000,000 shares authorized (2020: 169,371,322 issued and 118,288,296 outstanding; 2019: 168,973,172 issued and 119,555,207 outstanding)					—		—
Treasury stock, at cost (2020: 51,083,026 shares; 2019: 49,417,965 shares)					(3,995	)	(3,846	)
Additional paid-in capital	244		233		252		254
Retained earnings	6,431		5,847		6,576		6,399
Accumulated other comprehensive income (loss), net	(306	)	(247	)	(346	)	(300	)
Total Celanese Corporation stockholders' equity	2,747		2,984		2,487		2,507
Noncontrolling interests	392		395		382		391
Total equity	3,139		3,379		2,869		2,898
Total liabilities and equity	9,414		9,313		9,506		9,476

See the accompanying notes to the unaudited interim consolidated financial statements.

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY


	Three Months Ended September 30,								Three Months Ended June 30,
	2019				2018				2020				2019
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount
	(In $ millions, except share data)								(In $ millions, except share data)
Common Stock
Balance as of the beginning of the period	123,740,349		—		135,018,148		—		118,228,898		—		126,612,492		—
Stock option exercises									—		—		4,108		—
Purchases of treasury stock	(2,444,278	)	—		(1,292,375	)	—		—		—		(2,917,864	)	—
Stock awards	37,232		—		5,736		—		59,398		—		41,613		—
Balance as of the end of the period	121,333,303		—		133,731,509		—		118,288,296		—		123,740,349		—
Treasury Stock
Balance as of the beginning of the period	45,170,482		(3,347	)	33,276,096		(2,131	)	51,127,396		(3,996	)	42,285,459		(3,048	)
Purchases of treasury stock, including related fees	2,444,278		(275	)	1,292,375		(150	)	—		—		2,917,864		(300	)
Issuance of treasury stock under stock plans									(44,370	)	1		(32,841	)	1
Balance as of the end of the period	47,614,760		(3,622	)	34,568,471		(2,281	)	51,083,026		(3,995	)	45,170,482		(3,347	)
Additional Paid-In Capital
Balance as of the beginning of the period			233				208				242				224
Stock-based compensation, net of tax			11				14				10				9
Stock option exercises, net of tax			—				—
Balance as of the end of the period			244				222				252				233
Retained Earnings
Balance as of the beginning of the period			6,245				5,491				6,543				6,114
Net earnings (loss) attributable to Celanese Corporation			263				401				107				209
Common stock dividends			(77	)			(73	)			(74	)			(78	)
Balance as of the end of the period			6,431				5,819				6,576				6,245
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period			(267	)			(188	)			(341	)			(243	)
Other comprehensive income (loss), net of tax			(39	)			(31	)			(5	)			(24	)
Balance as of the end of the period			(306	)			(219	)			(346	)			(267	)
Total Celanese Corporation stockholders' equity			2,747				3,541				2,487				2,864
Noncontrolling Interests
Balance as of the beginning of the period			390				407				388				392
Net earnings (loss) attributable to noncontrolling interests			2				1				2				1
(Distributions to) contributions from noncontrolling interests			—				(6	)
Distributions to noncontrolling interests											(8	)			(3	)
Balance as of the end of the period			392				402				382				390
Total equity			3,139				3,943				2,869				3,254

See the accompanying notes to the unaudited interim consolidated financial statements.

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY


	Nine Months Ended September 30,								Six Months Ended June 30,
	2019				2018				2020				2019
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount
	(In $ millions, except share data)								(In $ millions, except share data)
Common Stock
Balance as of the beginning of the period	128,095,849		—		135,769,256		—		119,555,207		—		128,095,849		—
Stock option exercises	14,045		—		—		—		—		—		14,045		—
Purchases of treasury stock	(7,334,433	)	—		(2,180,758	)	—		(1,709,431	)	—		(4,890,155	)	—
Stock awards	557,842		—		143,011		—		442,520		—		520,610		—
Balance as of the end of the period	121,333,303		—		133,731,509		—		118,288,296		—		123,740,349		—
Treasury Stock
Balance as of the beginning of the period	40,323,105		(2,849	)	32,387,713		(2,031	)	49,417,965		(3,846	)	40,323,105		(2,849	)
Purchases of treasury stock, including related fees	7,334,433		(775	)	2,180,758		(250	)	1,709,431		(150	)	4,890,155		(500	)
Issuance of treasury stock under stock plans	(42,778	)	2		—		—		(44,370	)	1		(42,778	)	2
Balance as of the end of the period	47,614,760		(3,622	)	34,568,471		(2,281	)	51,083,026		(3,995	)	45,170,482		(3,347	)
Additional Paid-In Capital
Balance as of the beginning of the period			233				175				254				233
Stock-based compensation, net of tax			12				47				(2	)			1
Stock option exercises, net of tax			(1	)			—				—				(1	)
Balance as of the end of the period			244				222				252				233
Retained Earnings
Balance as of the beginning of the period			5,847				4,920				6,399				5,847
Net earnings (loss) attributable to Celanese Corporation			809				1,108				325				546
Common stock dividends			(225	)			(209	)			(148	)			(148	)
Balance as of the end of the period			6,431				5,819				6,576				6,245
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period			(247	)			(177	)			(300	)			(247	)
Other comprehensive income (loss), net of tax			(59	)			(42	)			(46	)			(20	)
Balance as of the end of the period			(306	)			(219	)			(346	)			(267	)
Total Celanese Corporation stockholders' equity			2,747				3,541				2,487				2,864
Noncontrolling Interests
Balance as of the beginning of the period			395				412				391				395
Net earnings (loss) attributable to noncontrolling interests			4				4				4				2
(Distributions to) contributions from noncontrolling interests			(7	)			(14	)
Distributions to noncontrolling interests											(13	)			(7	)
Balance as of the end of the period			392				402				382				390
Total equity			3,139				3,943				2,869				3,254

See the accompanying notes to the unaudited interim consolidated financial statements.

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS


	Nine Months Ended September 30,				Six Months Ended June 30,
	2019		2018		2020		2019
	(In $ millions)				(In $ millions)
Operating Activities
Net earnings (loss)	813		1,112		329		548
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Asset impairments	83		—		29		83
Depreciation, amortization and accretion	265		258		175		170
Pension and postretirement net periodic benefit cost	(44	)	(69	)	(49	)	(30	)
Pension and postretirement contributions	(35	)	(35	)	(23	)	(24	)
Deferred income taxes, net	(21	)	43		(15	)	(17	)
(Gain) loss on disposition of businesses and assets, net	2		5		1		1
Stock-based compensation	38		53		20		27
Undistributed earnings in unconsolidated affiliates	(8	)	(19	)	17		22
Other, net	15		18		10		13
Operating cash provided by (used in) discontinued operations	5		4		6		—
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net	55		(114	)	167		52
Inventories	34		(142	)	27		39
Other assets	(36	)	(60	)	84		(21	)
Trade payables - third party and affiliates	(44	)	44		(150	)	(51	)
Other liabilities	6		97		10		(81	)
Net cash provided by (used in) operating activities	1,128		1,195		638		731
Investing Activities
Capital expenditures on property, plant and equipment	(226	)	(244	)	(207	)	(144	)
Acquisitions, net of cash acquired	(91	)	(144	)	(88	)	(91	)
Proceeds from sale of businesses and assets, net	1		13		3		—
Other, net	(9	)	(34	)	(17	)	(8	)
Net cash provided by (used in) investing activities	(325	)	(409	)	(309	)	(243	)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less	127		(86	)	(136	)	105
Proceeds from short-term borrowings	110		44		306		—
Repayments of short-term borrowings	(85	)	(62	)	(50	)	(12	)
Proceeds from long-term debt	499		—		—		499
Repayments of long-term debt	(354	)	(56	)	(16	)	(348	)
Purchases of treasury stock, including related fees	(763	)	(250	)	(167	)	(488	)
Common stock dividends	(225	)	(209	)	(148	)	(148	)
(Distributions to) contributions from noncontrolling interests	(7	)	(14	)
Distributions to noncontrolling interests					(13	)	(7	)
Other, net	(38	)	(6	)	(24	)	(38	)
Net cash provided by (used in) financing activities	(736	)	(639	)	(248	)	(437	)
Exchange rate effects on cash and cash equivalents	(9	)	(20	)	(5	)	1
Net increase (decrease) in cash and cash equivalents	58		127		76		52
Cash and cash equivalents as of beginning of period	439		576		463		439
Cash and cash equivalents as of end of period	497		703		539		491

See the accompanying notes to the unaudited interim consolidated financial statements.

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

1. Description of the Company and Basis of Presentation

Description of the Company

Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.

Definitions

In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese US" refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.

Basis of Presentation

The unaudited interim consolidated financial statements for the three and ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~2019 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.

In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with US GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, ~~2018~~2019, filed on February ~~7, 2019~~6, 2020 with the SEC as part of the Company's Annual Report on Form 10-K.

Operating results for the three and ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 are not necessarily indicative of the results to be expected for the entire year.

In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.

For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as noncontrolling interests.

~~The Company has reclassified certain prior period amounts to conform to the presentation of the Company's current reportable segments.~~

Table of Contents

Estimates and Assumptions

The preparation of unaudited interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.

2. Recent Accounting Pronouncements

The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB"):



Standard	Description	Effective Date	Effect on the Financial Statements or Other Significant Matters

In ~~August 2018,~~March 2020, the FASB issued ASU ~~2018-14, Disclosure Framework - Changes to~~2020-04, Facilitation of the ~~Disclosure Requirements for Defined Benefit Plans.~~Effects of Reference Rate Reform on Financial Reporting.	The new guidance ~~modifies the disclosure requirements~~provides optional expedients and exceptions for ~~employers~~applying US GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The guidance applies only to contracts, hedging relationships and other transactions that ~~sponsor defined benefit pension~~reference LIBOR or ~~other postretirement plans by removing disclosures that no longer are considered cost beneficial, clarifying the specific requirements~~another reference rate expected to be discontinued because of ~~disclosures and adding disclosure requirements identified as relevant.~~reference rate reform.	~~January 1, 2020. Early adoption is permitted.~~March 12, 2020 through December 31, 2022.	The Company is currently evaluating the impact of adoption on its financial statements and related ~~disclosures, but does not anticipate a material impact to the consolidated financial statements.~~disclosures.

In ~~February 2018,~~December 2019, the FASB issued ASU ~~2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.~~2019-12, Simplifying the Accounting for Income Taxes.	The new guidance ~~allows a reclassification from accumulated other comprehensive~~simplifies the accounting for income taxes by removing certain exceptions to ~~retained earnings for stranded tax effects resulting from~~ the ~~Tax Cuts~~general principles in FASB Accounting Standards Codification Topic 740, Income Taxes ("Topic 740"). The guidance also clarifies and ~~Jobs Act and will improve the usefulness of information reported to financial statement users.~~amends existing guidance under Topic 740.	January 1, ~~2019.~~2021. Early adoption is permitted.	The Company ~~adopted~~has completed its assessment and will adopt the new guidance effective January1, ~~2019.~~2021. The adoption of the new guidance ~~did~~will not have a material impact onto the Company.

~~In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU 2016-13.~~	The new guidance requires financial instruments measured at amortized cost basis to be presented at the net amount expected to be collected through application of the current expected credit losses model. The model requires an estimate of the credit losses expected over the life of an exposure or pool of exposures. The income statement will reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period.	~~January 1, 2020. Early adoption is permitted.~~	~~The Company is currently evaluating the impact of adoption on its financial statements and related disclosures, but does not anticipate a material impact to the consolidated financial statements.~~

~~In February 2016, the FASB issued ASU 2016-02, Leases. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU 2016-02.~~	The new guidance supersedes the lease guidance under FASB Accounting Standards Codification ("ASC") Topic 840, Leases, resulting in the creation of FASB ASC Topic 842, Leases. The guidance requires a lessee to recognize in the statement of financial position a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term for both finance and operating leases. Subsequent guidance issued after February 2016 did not change the core principle of ASU 2016-02.	~~January 1, 2019.~~	~~The Company adopted the new guidance effective January 1, 2019, using the modified retrospective transition method, which did not require the Company to adjust comparative periods. See the~~ ~~Adoption of ASU 2016-02~~ ~~section below for additional information.~~

~~Table of Contents~~

~~Adoption of ASU 2016-02, Leases~~

The Company adopted ASU 2016-02 as of January 1, 2019, using the modified retrospective approach. Prior period amounts have not been adjusted. In addition, the Company elected the following practical expedients:

~~the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification;~~

~~the land easements practical expedient, which allowed the Company to carry forward the accounting treatment for land easements on existing agreements;~~

~~the short-term lease practical expedient, which allowed the Company to exclude short-term leases from recognition in the unaudited consolidated balance sheets; and~~

~~the bifurcation of lease and non-lease components practical expedient, which did not require the Company to bifurcate lease and non-lease components for all classes of assets.~~

The adoption of this accounting standard resulted in the recording of Operating lease right-of-use ("ROU") assets and Operating lease liabilities of $223 million and $240 million, respectively, as of January 1, 2019. The difference between the operating lease assets and liabilities was recorded as an adjustment to Other liabilities, primarily related to deferred rent (lease incentives). The adoption of ASU 2016-02 had no impact on Retained earnings.

~~See~~ ~~Note 16~~ ~~for additional information.~~

3. ~~Acquisitions, Dispositions and Plant Closures~~

~~Plant Closures~~

~~Ocotlán, Mexico~~

On June 28, 2019, the Company announced it will consolidate its global acetate manufacturing capabilities with the closure of its acetate flake manufacturing operations in Ocotlán, Mexico. The Ocotlán, Mexico operations are included in the Company's Acetate Tow segment.

~~The exit and shutdown costs related to this closure are as follows:~~



	Nine Months Ended September 30, 2019
	~~(In $ millions)~~
~~Asset impairments~~⁽¹⁾	83
~~Restructuring~~⁽¹⁾	3
~~Accelerated depreciation expense~~	7
~~Loss on disposition of assets, net~~	1
~~Other~~⁽¹⁾	1
~~Total~~	95

~~______________________________~~


⁽¹⁾	~~Included in Other (charges) gains, net in the unaudited interim consolidated statement of operations (Note 14~~).

~~The Company expects to incur additional exit and shutdown costs related to Ocotlán, Mexico of approximately $12 million through the first quarter of 2020.~~

4. Ventures and Variable Interest Entities

Consolidated Variable Interest Entities

The Company has a joint venture, Fairway Methanol LLC ("Fairway"), with Mitsui & Co., Ltd., of Tokyo, Japan ("Mitsui"), in which the Company owns 50% of Fairway, for the production of methanol at the Company's integrated chemical plant in Clear Lake, Texas. The methanol unit utilizes natural gas in the US Gulf Coast region as a feedstock and benefits from the existing

~~Table of Contents~~

infrastructure at the Company's Clear Lake facility. Both Mitsui and the Company supply their own natural gas to Fairway in exchange for methanol tolling under a cost-plus off-take arrangement.

~~The Company determined that~~ Fairway is a variable interest entity ("VIE") in which the Company is the primary beneficiary. Under the terms of the joint venture agreements, the Company provides site services and day-to-day operations for the methanol facility. In addition, the joint venture agreements provide that the Company indemnifies Mitsui for environmental obligations that exceed a specified threshold, as well as an equity option between the partners. Accordingly, the Company consolidates the venture and records a noncontrolling interest for the share of the venture owned by Mitsui. Fairway is included in the Company's Acetyl Chain segment.

Table of Contents

The carrying amount of the assets and liabilities associated with Fairway included in the unaudited consolidated balance sheets are as follows:


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Cash and cash equivalents	46	24	33	57
Trade receivables, net - third party and affiliates	13	11	10	12
Property, plant and equipment (net of accumulated depreciation - 2019: $161; 2018: $130)	631	659
Intangible assets (net of accumulated amortization - 2019: $4; 2018: $3)	22	23
Non-trade receivables, net			2	—
Property, plant and equipment (net of accumulated depreciation - 2020: $191; 2019: $174)			612	622
Other assets	2	5	15	9
Intangible assets (net of accumulated amortization - 2020: $4; 2019: $4)			22	22
Total assets⁽¹⁾	714	722	694	722

Trade payables	16	16	11	24
Other liabilities⁽²⁾	3	4	10	5
Total debt	4	5	3	4
Deferred income taxes	4	3	4	4
Total liabilities	27	28	28	37

______________________________


⁽¹⁾	~~Assets~~Joint venture assets can only be used to settle the obligations of Fairway.


⁽²⁾	Primarily represents amounts owed by Fairway to the Company for reimbursement of expenditures.

Nonconsolidated Variable Interest Entities

The Company holds variable interests in entities that supply certain raw materials and services to the Company. The variable interests primarily relate to cost-plus contractual arrangements with the suppliers and recovery of capital expenditures for certain plant assets plus a rate of return on such assets. Liabilities for such supplier recoveries of capital expenditures have been recorded as finance lease obligations. The entities are not consolidated because the Company is not the primary beneficiary of the entities as it does not have the power to direct the activities of the entities that most significantly impact the entities' economic performance. The Company's maximum exposure to loss as a result of its involvement with these VIEs as of ~~September~~June 30, ~~2019,~~2020, relates primarily to the recovery of capital expenditures for certain property, plant and equipment.

~~Table of Contents~~

The carrying amount of the assets and liabilities associated with the obligations to nonconsolidated VIEs, as well as the maximum exposure to loss relating to these nonconsolidated VIEs are as follows:


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Property, plant and equipment, net	32	42	25	31

Trade payables	30	27	22	30
Current installments of long-term debt	15	14	17	16
Long-term debt	46	58	33	41
Total liabilities	91	99	72	87

Maximum exposure to loss	119	134	93	113

The difference between the total liabilities associated with obligations to nonconsolidated VIEs and the maximum exposure to loss primarily represents take-or-pay obligations for services included in the Company's unconditional purchase obligations (Note 1916).

~~5. Marketable Securities~~

The Company's nonqualified trusts hold available-for-sale securities for funding requirements of the Company's nonqualified pension plans. Available-for-sale securities as of September 30, 2019 and December 31, 2018 were $26 million and $31 million, respectively, and were recorded at amortized cost, which approximates fair value.

6.Table of Contents

4. Inventories


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Finished goods	668	697	713	718
Work-in-process	78	70	67	76
Raw materials and supplies	248	279	251	244
Total	994	1,046	1,031	1,038

7.5. Goodwill and Intangible Assets, Net

Goodwill


	Engineered Materials			Acetate Tow		Acetyl Chain		Total		Engineered Materials		Acetate Tow		Acetyl Chain		Total
	(In $ millions)									(In $ millions)
As of December 31, 2018	707			148		202		1,057
As of December 31, 2019										727		148		199		1,074
Acquisitions	29		⁽¹⁾	—		—		29		—		—		28	⁽¹⁾	28
Exchange rate changes	(22	)		(1	)	(9	)	(32	)	(3	)	(1	)	—		(4	)
As of September 30, 2019	714			147		193		1,054
As of June 30, 2020⁽²⁾										724		147		227		1,098

______________________________


⁽¹⁾	Represents goodwill related to the acquisition of ~~Next Polymers Ltd.~~Nouryon's redispersible polymer powders business offered under the Elotex^® brand ("Elotex").

The Company assesses the recoverability of the carrying amount of its reporting unit goodwill either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. In connection with the Company's annual goodwill impairment assessment, the Company did not record an impairment loss to goodwill during the nine months

~~Table of Contents~~


⁽²⁾ ~~ended September 30, 2019 as the estimated fair value for each of the Company's reporting units exceeded the carrying amount of the underlying assets by a substantial margin.~~	There were $0 million of accumulated impairment losses as of June 30, 2020.

Intangible Assets, Net

Finite-lived intangible assets are as follows:


	Licenses		Customer- Related Intangible Assets		Developed Technology		Covenants Not to Compete and Other		Total			Licenses		Customer- Related Intangible Assets			Developed Technology		Covenants Not to Compete and Other		Total
	(In $ millions)											(In $ millions)
Gross Asset Value
As of December 31, 2018	42		651		44		56		793
As of December 31, 2019												42		667			44		56		809
Acquisitions	—		25		—		—		25		⁽¹⁾	—		16		⁽¹⁾	—		—		16
Exchange rate changes	(1	)	(22	)	(1	)	—		(24	)		(1	)	(3	)		—		—		(4	)
As of September 30, 2019	41		654		43		56		794
As of June 30, 2020												41		680			44		56		821
Accumulated Amortization
As of December 31, 2018	(33	)	(495	)	(32	)	(35	)	(595	)
As of December 31, 2019												(35	)	(504	)		(35	)	(38	)	(612	)
Amortization	(1	)	(12	)	(3	)	(2	)	(18	)		(1	)	(8	)		(2	)	—		(11	)
Exchange rate changes	2		18		—		—		20			1		1			—		—		2
As of September 30, 2019	(32	)	(489	)	(35	)	(37	)	(593	)
As of June 30, 2020												(35	)	(511	)		(37	)	(38	)	(621	)
Net book value	9		165		8		19		201			6		169			7		18		200

______________________________


⁽¹⁾	~~Represents~~Related to acquired Elotex finite-lived intangible assets, ~~acquired related to Next Polymers Ltd.~~ with a weighted average amortization period of 1314 years.

Table of Contents

Indefinite-lived intangible assets are as follows:



	Trademarks and Trade Names
	(In $ millions)
As of December 31, ~~2018~~2019	~~112~~115
Acquisitions	42		⁽¹⁾
~~Accumulated impairment losses~~	—
~~Exchange rate changes~~	(3	)
As of ~~September~~June 30, ~~2019~~2020	~~113~~117

______________________________


⁽¹⁾	~~Represents~~Related to acquired Elotex indefinite-lived intangible ~~assets related to the acquisition of Next Polymers Ltd.~~assets.

The Company assesses the recoverability of the carrying amount of its indefinite-lived intangible assets either qualitatively or by utilizing the relief from royalty method under the income approach annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. In connection with the Company's annual indefinite-lived intangible assets impairment assessment, the Company did not record an impairment loss to indefinite-lived intangible assets during the nine months ended September 30, 2019 as the estimated fair value of each of the Company's indefinite-lived intangible assets exceeded the carrying value of the underlying assets by a substantial margin.

During the ~~nine~~six months ended ~~September~~June 30, ~~2019,~~2020, the Company did not renew or extend any intangible assets.

~~Table of Contents~~

Estimated amortization expense for the succeeding five fiscal years is as follows:


	(In $ millions)	(In $ millions)
2020	21
2021	21	22
2022	19	21
2023	17	18
2024	16	17
2025		17

8.6. Current Other Liabilities

As of
September 30,
2019 As of
December 31,
2018
(In $ millions)
Asset retirement obligations 9
3
Benefit obligations (Note 11)
30
30
Customer rebates (Note 21)
62
76
Derivatives (Note 17)
10
7
Environmental (Note 12)
11
20
Insurance 6
4
Interest 28
21
Operating leases (Note 16)
31
—
Restructuring (Note 14)
16
4
Salaries and benefits 80
119
Sales and use tax/foreign withholding tax payable 28
22
Other 47
37
Total 358
343

~~9. Noncurrent Other Liabilities~~


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Asset retirement obligations	12	13	3	6
Deferred proceeds	42	44
Deferred revenue (Note 21)	6	7
Derivatives (Note 17)	58	11
Environmental (Note 12)	52	49
Benefit obligations (Note 9)			28	28
Customer rebates			37	63
Derivatives (Note 14)			97	8
Environmental (Note 10)			19	12
Insurance	42	37	4	6
Interest			26	29
Legal (Note 16)			98	105
Operating leases			29	29
Restructuring (Note 12)			10	13
Salaries and benefits			90	89
Sales and use tax/foreign withholding tax payable			98	35
Other	28	47	33	38
Total	240	208	572	461

1513

Table of Contents

~~10.~~7. Noncurrent Other Liabilities



	As of June 30, 2020	As of December 31, 2019
	(In $ millions)
Asset retirement obligations	15	13
Deferred proceeds	43	43
Deferred revenue (Note 18)	6	6
Derivatives (Note 14)	3	50
Environmental (Note 10)	48	49
Insurance	39	34
Other	25	28
Total	179	223

8. Debt


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt	26	367	427	28
Short-term borrowings, including amounts due to affiliates⁽¹⁾	68	77	377	81
Revolving credit facility⁽²⁾	159	40	154	272
Accounts receivable securitization facility⁽³⁾	115	77	87	115
Total	368	561	1,045	496

______________________________


⁽¹⁾	The weighted average interest rate was ~~2.9%~~1.2% and ~~3.2%~~2.3% as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, respectively. During the six months ended June 30, 2020, the Company entered into an aggregate of $300 million in short-term, bilateral term loans.


⁽²⁾	The weighted average interest rate was ~~1.3%~~1.5% and ~~6.0%~~1.6% as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, respectively.


⁽³⁾	The weighted average interest rate was ~~2.9%~~0.9% and ~~3.1%~~2.4% as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, respectively.

As of
September 30,
2019 As of
December 31,
2018
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2019, interest rate of 3.250% —
343
Senior unsecured notes due 2021, interest rate of 5.875% 400
400
Senior unsecured notes due 2022, interest rate of 4.625% 500
500
Senior unsecured notes due 2023, interest rate of 1.125% 816
857
Senior unsecured notes due 2024, interest rate of 3.500% 499
—
Senior unsecured notes due 2025, interest rate of 1.250% 326
343
Senior unsecured notes due 2027, interest rate of 2.125% 541
568
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00% 167
167
Nilit bank loans due at various dates through 2026⁽¹⁾
9
10
Obligations under finance leases due at various dates through 2054 146
167
Subtotal 3,404
3,355
Unamortized debt issuance costs⁽²⁾
(19 ) (18 )
Current installments of long-term debt (26 ) (367 )
Total 3,359
2,970

Table of Contents



	As of June 30, 2020		As of December 31, 2019
	(In $ millions)
Long-Term Debt
Senior unsecured notes due 2021, interest rate of 5.875%	400		400
Senior unsecured notes due 2022, interest rate of 4.625%	500		500
Senior unsecured notes due 2023, interest rate of 1.125%	839		841
Senior unsecured notes due 2024, interest rate of 3.500%	499		499
Senior unsecured notes due 2025, interest rate of 1.250%	336		337
Senior unsecured notes due 2027, interest rate of 2.125%	556		558
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%	167		167
Bank loans due at various dates through 2026⁽¹⁾	8		9
Obligations under finance leases due at various dates through 2054	128		144
Subtotal	3,433		3,455
Unamortized debt issuance costs⁽²⁾	(17	)	(18	)
Current installments of long-term debt	(427	)	(28	)
Total	2,989		3,409

______________________________


⁽¹⁾	The weighted average interest rate was 1.3% and 1.3% as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, respectively.


⁽²⁾	Related to the Company's long-term debt, excluding obligations under finance leases.

Senior Credit Facilities

~~On January 7, 2019, Celanese, Celanese US and certain subsidiary borrowers entered into~~The Company has a ~~new~~ senior credit agreement (the "Credit Agreement") consisting of a $1.25 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2024. The Credit Agreement is guaranteed by Celanese, Celanese US and substantially all of its domestic subsidiaries ("the Subsidiary Guarantors").

~~Table of Contents~~

The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facility are as follows:



	As of ~~September~~June 30, ~~2019~~2020
	(In $ millions)
Revolving Credit Facility
Borrowings outstanding⁽¹⁾	~~159~~
~~Letters of credit issued~~	—154
Available for borrowing⁽²⁾	~~1,091~~1,096

______________________________


⁽¹⁾	The Company borrowed ~~$982~~$385 million and repaid ~~$856~~$503 million under its senior unsecured revolving credit facility during the ~~nine~~six months ended ~~September~~June 30, ~~2019.~~2020.


⁽²⁾	The margin for borrowings under the senior unsecured revolving credit facility was ~~1.25%~~1.5% above LIBOR or EURIBOR at current Company credit ratings.

Senior Notes

The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese US and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese US may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.

~~On May 8, 2019, Celanese US completed an offering~~Table of $500 million in principal amount of 3.500% senior unsecured notes due May 8, 2024 (the "3.500% Notes") in a public offering registered under the Securities Act. The 3.500% Notes were issued at a discount to par at a price of 99.895%, which is being amortized to Interest expense in the unaudited interim consolidated statement of operations over the term of the 3.500% Notes. Net proceeds from the sale of the 3.500% Notes were used to redeem in full the 3.250% senior unsecured notes due October 15, 2019 (the "3.250 Notes"), to repay $156 million of outstanding borrowings under the senior unsecured revolving credit facility and for general corporate purposes. In connection with the issuance of the 3.500% Notes, the Company entered into a cross-currency swap to effectively convert its fixed-rate US dollar denominated debt under the 3.500% Notes, including annual interest payments and the payment of principal at maturity, to fixed-rate Euro denominated debt. See ~~Note 17~~Contents ~~for additional information.~~

Accounts Receivable Securitization Facility

The Company has a US accounts receivable securitization facility involving receivables of certain of its domestic subsidiaries of the Company transferred to a wholly-owned, "bankruptcy remote" special purpose subsidiary of the Company ("SPE"). The securitization facility, which permits cash borrowings and letters of credit, was amended and restated on July ~~8, 2019 to extend the maturity date to July~~ 6, ~~2020 and modify certain events of default, limitations on concentrations of obligors and certain of the components used to calculate the SPE reserves.~~2020. All of the SPE's assets ~~have been~~were pledged to the administrative agent in support of the SPE's obligations under the facility.

See ~~Table of Contents~~Note 21

for further information.

The Company's debt balances and amounts available for borrowing under its securitization facility are as follows:



	As of ~~September~~June 30, ~~2019~~2020
	(In $ millions)
Accounts Receivable Securitization Facility
Borrowings outstanding⁽¹⁾	~~115~~
~~Letters of credit issued~~	—87
Available for borrowing	5
Total borrowing base	~~120~~92

Maximum borrowing base⁽¹⁾⁽²⁾	120

______________________________


⁽¹⁾	The Company repaid $28 million under its US accounts receivable securitization facility during the six months ended June 30, 2020.


⁽²⁾	Outstanding accounts receivable transferred to the SPE was ~~$182~~$117 million.

Other Financing Arrangements

~~In June 2018, the~~The Company ~~entered into~~has a factoring agreement with a global financial institution to sell certain accounts receivable on a non-recourse basis. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized ~~$196~~$110 million and ~~$117~~$257 million of accounts receivable under this factoring agreement as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, respectively.

Covenants

The Company's material financing arrangements contain customary covenants, including the maintenance of certain financial ratios, events of default and change of control provisions. Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with all of the covenants related to its debt agreements as of ~~September~~June 30, ~~2019~~2020.

~~11.~~

Table of Contents

9. Benefit Obligations

The components of net periodic benefit cost are as follows:


	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018			2020			2019			2020			2019
	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits	Pension Benefits		Post-retirement Benefits
	(In $ millions)												(In $ millions)
Service cost	3		—	2		—	7		—	7		—	3		—	2		—	6		—	4		—
Interest cost	28		1	26		1	86		2	78		2	21		—	29		1	42		1	58		1
Expected return on plan assets	(46	)	—	(52	)	—	(139	)	—	(157	)	—	(49	)	—	(47	)	—	(99	)	—	(93	)	—
Special termination benefit	—		—	—		—	—		—	1		—	1		—	—		—	1		—	—		—
Total	(15	)	1	(24	)	1	(46	)	2	(71	)	2	(24	)	—	(16	)	1	(50	)	1	(31	)	1

~~Table of Contents~~

Benefit obligation funding is as follows:


	As of September 30, 2019	Total Expected 2019	As of June 30, 2020	Total Expected 2020
	(In $ millions)		(In $ millions)
Cash contributions to defined benefit pension plans	16	22	11	23
Benefit payments to nonqualified pension plans	16	21	10	20
Benefit payments to other postretirement benefit plans	3	5	2	5
Cash contributions to German multiemployer defined benefit pension plans⁽¹⁾	6	9	4	8

______________________________


⁽¹⁾	The Company makes contributions based on specified percentages of employee contributions.

The Company's estimates of its US defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.

~~12.~~10. Environmental

The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.

The components of environmental remediation liabilities are as follows:


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Demerger obligations (Note 19)	24	26
Divestiture obligations (Note 19)	12	16
Demerger obligations (Note 16)			28	23
Divestiture obligations (Note 16)			13	12
Active sites	13	14	12	13
US Superfund sites	12	11	12	11
Other environmental remediation liabilities	2	2	2	2
Total	63	69	67	61

Table of Contents

Remediation

Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or US Superfund sites (as defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note ~~19)~~16). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued ~~operations.~~operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.

US Superfund Sites

In the US, the Company may be subject to substantial claims brought by US federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the US Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the US Environmental

~~Table of Contents~~

Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.

As events progress at each site for which it has been named a PRP, the Company accrues ~~as appropriate, a liability for site cleanup. Such liabilities include all costs that are~~any probable and ~~can be~~ reasonably ~~estimated.~~estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.

One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the Lower Passaic River Site and the Newark Bay Area. Work on the RI/FS is ongoing.

In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. OnIn June ~~30,~~ 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273-JLL-JAD (U.S. District Court New Jersey), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs. The Company is vigorously defending these matters and currently believes that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, estimated at less than 1%, will not be material to the Company's results of operations, cash flows or financial position.

~~13.~~

Table of Contents

11. Stockholders' Equity

Common Stock

The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing senior credit facility and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.

The Company's Board of Directors approved increases in the Company's Common Stock cash dividend rates as follows:

Increase

Quarterly Common

Stock Cash Dividend

Annual Common

Stock Cash Dividend

Effective Date

Increase

Quarterly Common

Stock Cash Dividend

Annual Common

Stock Cash Dividend

Effective Date

(In percentages)

(In $ per share)

(In percentages)

(In $ per share)

April 2018

0.54

2.16

May 2018

April 2019

0.62

2.48

May 2019

0.62

2.48

May 2019

April 2020

—

0.62

2.48

May 2020

~~Table of Contents~~

The Company declared a quarterly cash dividend of $0.62 per share on its Common Stock on ~~October 16, 2019,~~July 15, 2020, amounting to ~~$75~~$73 million. The cash dividend will be paid on ~~November 7, 2019~~August 6, 2020 to holders of record as of ~~October 28, 2019.~~July 27, 2020.

Treasury Stock

~~Treasury~~The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.


	Nine Months Ended September 30,				Total From February 2008 Through September 30, 2019		Six Months Ended June 30,				Total From February 2008 Through June 30, 2020
	2019		2018		Total From February 2008 Through September 30, 2019		2020		2019		Total From February 2008 Through June 30, 2020
Shares repurchased	7,334,433		2,179,058		55,047,144		1,709,431		4,890,155		58,588,409
Average purchase price per share	$	105.67	$	114.73	$	71.35	$	87.87	$	102.25	$	73.44
Shares repurchased (in $ millions)	$	775	$	250	$	3,928	$	150	$	500	$	4,303
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)⁽¹⁾	$	1,500	$	—	$	5,366	$	—	$	1,500	$	5,366

~~______________________________~~


⁽¹⁾ On July 15, 2020, the Company's Board of Directors approved a $500 million increase in its Common Stock repurchase authorization. As of June 30, 2020, the Company had $1.1 billion remaining under the previous authorization.	These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program began in February 2008 and does not have an expiration date.

The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of stockholders' equity.

Other Comprehensive Income (Loss), Net

Three Months Ended September 30,
2019 2018

Gross
Amount

Income
Tax
(Provision)
Benefit

Net
Amount

Gross
Amount

Income
Tax
(Provision)
Benefit
Net
Amount
(In $ millions)
Foreign currency translation gain (loss) (4 ) (3 ) (7 ) (31 ) (4 ) (35 )
Gain (loss) on cash flow hedges (33 ) 1
(32 ) 4
—
4
Pension and postretirement benefits gain (loss) —
—
—
—
—
—
Total (37 ) (2 ) (39 ) (27 ) (4 ) (31 )

Nine Months Ended September 30,
2019 2018
Gross
Amount Income
Tax
(Provision)
Benefit Net
Amount Gross
Amount Income
Tax
(Provision)
Benefit Net
Amount
(In $ millions)
Foreign currency translation gain (loss) (3 ) (8 ) (11 ) (58 ) 6
(52 )
Gain (loss) on cash flow hedges (55 ) 7
(48 ) 8
1
9
Pension and postretirement benefits gain (loss) —
—
—
1
—
1
Total (58 ) (1 ) (59 ) (49 ) 7
(42 )



	Three Months Ended June 30,
	2020					2019
	Gross Amount		Income Tax (Provision) Benefit	Net Amount		Gross Amount		Income Tax (Provision) Benefit	Net Amount
	(In $ millions)
Foreign currency translation gain (loss)	(10	)	4	(6	)	(12	)	1	(11	)
Gain (loss) on cash flow hedges	1		—	1		(19	)	6	(13	)
Total	(9	)	4	(5	)	(31	)	7	(24	)

2119

Table of Contents



	Six Months Ended June 30,
	2020						2019
	Gross Amount		Income Tax (Provision) Benefit		Net Amount		Gross Amount		Income Tax (Provision) Benefit		Net Amount
	(In $ millions)
Foreign currency translation gain (loss)	—		(8	)	(8	)	1		(5	)	(4	)
Gain (loss) on cash flow hedges	(50	)	12		(38	)	(22	)	6		(16	)
Total	(50	)	4		(46	)	(21	)	1		(20	)

Adjustments to Accumulated other comprehensive income (loss), net, are as follows:

Foreign
Currency
Translation Gain (Loss)

Gain (Loss)
on Cash
Flow
Hedges
(Note 17)

Pension
and
Postretirement
Benefits Gain (Loss)
(Note 11)

Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2018 (236 ) (8 ) (3 ) (247 )
Other comprehensive income (loss) before reclassifications (3 ) (50 ) —
(53 )
Amounts reclassified from accumulated other comprehensive income (loss) —
(5 )
—

(5 )
Income tax (provision) benefit (8 ) 7
—
(1 )
As of September 30, 2019 (247 ) (56 ) (3 ) (306 )



	Foreign Currency Translation Gain (Loss)		Gain (Loss) on Cash Flow Hedges (Note 14)		Pension and Postretirement Benefits Gain (Loss) (Note 9)		Accumulated Other Comprehensive Income (Loss), Net
	(In $ millions)
As of December 31, 2019	(252	)	(38	)	(10	)	(300	)
Other comprehensive income (loss) before reclassifications	—		(50	)	—		(50	)
Income tax (provision) benefit	(8	)	12		—		4
As of June 30, 2020	(260	)	(76	)	(10	)	(346	)

~~14.~~12. Other (Charges) Gains, Net


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018		2020		2019		2020		2019
	(In $ millions)								(In $ millions)
Restructuring	(6	)	(1	)	(20	)	(4	)	(2	)	(15	)	(8	)	(14	)
Asset impairments	—		—		(83	)	—		(25	)	(83	)	(29	)	(83	)
Plant/office closures	(1	)	13		(2	)	13		6		—		5		(1	)
Commercial disputes	—		—		4		—		1		—		6		4
European Commission investigation									(2	)	—		(2	)	—
Other									1		—		1		—
Total	(7	)	12		(101	)	9		(21	)	(98	)	(27	)	(94	)

During the ~~nine~~three months ended ~~September~~June 30, 2020, the Company determined that certain fixed assets at three manufacturing sites within Europe should be assessed for impairment based on the Company's intention to establish a Compounding Center of Excellence at its Forli, Italy manufacturing location by consolidating the compounding operations at its facilities in Kaiserslautern, Germany; Wehr, Germany and Ferrara Marconi, Italy into the Forli, Italy location. As a result, the Company concluded that certain long-lived assets were impaired. Accordingly, the Company recorded a long-lived asset impairment loss of $25 million, which was measured at the date of impairment. The asset impairment was included in the Company's Engineered Materials segment.

During the six months ended June 30, 2020, the Company recorded a $4 million long-lived asset impairment loss related to the closure of its manufacturing operations in Lebanon, Tennessee. The long-lived asset impairment loss was measured at the date of impairment to write-down the related property, plant and equipment and was included in the Company's Engineered Materials segment.

During the six months ended June 30, 2019, the Company recorded an $83 million long-lived asset impairment loss related to the closure of its acetate flake manufacturing operations in Ocotlán, ~~Mexico (Note 3~~).Mexico. The long-lived asset impairment loss was measured at the date of impairment to write-off the related property, plant and equipment and was included in the Company's Acetate Tow segment.

Table of Contents

During the ~~nine~~three months ended ~~September~~June 30, 2020, the Company recorded a $6 million gain within plant/office closures related to receipt of a non-income tax credit from Nanjing, China, which was included in the Company's Acetyl Chain segment.

During the six months ended June 30, 2020, the Company recorded a $6 million gain within commercial disputes, primarily related to the receipt of a settlement claim from a previous acquisition that was included within the Company's Engineered Materials segment. During the six months ended June 30, 2019, the Company recorded a $15 million gain within commercial disputes related to a settlement from a previous acquisition that was included within the Company's Engineered Materials segment. The Company also recorded an $11 million loss within commercial disputes related to a settlement ~~by the Company's captive insurer~~ with a former third-party customer, which was included within the Company's Other Activities segment.

During the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~September 30, 2018,~~2019, the Company recorded ~~$20~~$8 million and $4$14 million, respectively, of employee termination benefits primarily related to Company-wide business optimization projects.

During the nine months ended September 30, 2018, the Company recorded a $13 million gain within plant/office closures related to a non-income tax receivable refund from Nanjing, China, in its Acetyl Chain segment.

~~Table of Contents~~

The changes in the restructuring ~~liability~~liabilities by business segment are as follows:

Engineered
Materials
Acetate Tow Acetyl Chain Other Total
(In $ millions)
Employee Termination Benefits
As of December 31, 2018 —
2
2
—
4
Additions 9
3
1
8
21
Cash payments (4 ) (2 ) —
(3 ) (9 )
Other changes —
—
(1 ) —
(1 )
Exchange rate changes —
—
—
—
—
As of September 30, 2019 5
3
2
5
15
Plant/Office Closures
As of December 31, 2018 —
—
—
—
—
Additions —
1
—
—
1
Cash payments —
—
—
—
—
Other changes —
—
—
—
—
Exchange rate changes —
—
—
—
—
As of September 30, 2019 —
1
—
—
1
Total 5
4
2
5
16



	Engineered Materials		Acetate Tow		Acetyl Chain		Other		Total
	(In $ millions)
Employee Termination Benefits
As of December 31, 2019	5		3		—		5		13
Additions	3		—		1		7		11
Cash payments	(3	)	(2	)	(1	)	(5	)	(11	)
Other changes	(2	)	—		—		(1	)	(3	)
As of June 30, 2020	3		1		—		6		10

~~15.~~13. Income Taxes

Three Months Ended
September 30, Nine Months Ended
September 30,
2019 2018 2019 2018
(In percentages)
Effective income tax rate 16 12 13 16



	Three Months Ended June 30,		Six Months Ended June 30,
	2020	2019	2020	2019
	(In percentages)
Effective income tax rate	24	12	23	12

The higher effective income tax rate for the three and six months ended ~~September~~June 30, ~~2019~~2020 compared to the same ~~period~~periods in ~~2018~~2019 was primarily due to adjustments to the recorded impacts of certain uncertain tax positions due to available tax attribute carryforwards, the impact of functional currency differences in offshore jurisdictions ~~partially offset by~~and the ~~release~~increased tax rate impact of ~~the valuation allowance on foreign tax credit carryforwards~~such items due to ~~a change~~lower earnings in the ~~sourcing of US earnings between domestic and foreign sources.~~

~~The lower effective income tax rate for the nine months ended September 30, 2019 compared~~current year due to the ~~same period in 2018 was primarily due to 2019 reductions in the valuation allowance on foreign tax credits that resulted from greater forecasted utilization of credits prior~~global pandemic related to the ~~expiration~~outbreak of ~~the carryforward period. During the nine months ended September 30, 2018, and prior~~a novel coronavirus ("COVID-19").

Due to ~~the receipt of any regulatory guidance from the US Department of Treasury ("US Treasury") related to various provisions of~~ the Tax Cuts and Jobs Act ("TCJA"), the Company recorded additional valuation allowances on prior year foreign tax credit carryforwards due to uncertainty regarding the treatment of future income and credits generated under the global low-taxed intangible income ("GILTI") provisions, which were enacted as part of TCJA.

The Company evaluates its deferred tax assets on a quarterly basis to determine whether a valuation allowance is necessary. Realization of deferred tax assets ultimately depends on the existence of sufficient taxable income in the applicable carryback or carryforward periods. Changes in the Company's estimates of future taxable income and prudent and feasible tax planning strategies will affect the estimate of the realization of the tax benefits of these foreign tax credit carryforwards. Due to the TCJA and uncertainty as to future ~~sources of general limitation~~ foreign source income, ~~to allow for the utilization of these credits,~~ the Company previously recorded a valuation allowance on a substantial portion of its foreign tax ~~credits upon the enactment of the TCJA.~~credits. The Company is currently evaluating tax planning strategies that would ~~utilize~~allow utilization of the Company's foreign tax credit carryforwards. Implementation of these strategies in future periods could reduce the level of valuation allowance that is needed, thereby decreasing the Company's effective tax rate.

~~On March 6, 2019, the~~The US Treasury issued additional final and proposed ~~regulations clarifying~~guidance supplementing the ~~deduction for GILTI and Foreign-Derived Intangible Income ("FDII"),~~TCJA provisions in 2019, which ~~were enacted as part of~~ the ~~TCJA. The~~ Company ~~currently~~ does not expect ~~these regulations~~to have a material impact on current or future income tax expense. The US Treasury issued further guidance in July 2020 that is not effective until published in the Federal Register. The Company will continue to monitor the expected impacts on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period that the guidance is finalized.

In response to COVID-19, various global taxing authorities passed or are considering relief initiatives to aid tax payers from an effective tax rate or cash flow perspective. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") was enacted in the US in response to the global pandemic. The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of social security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property and the creation of certain refundable employee retention credits. The

2321

Table of Contents

Company does not currently expect the CARES Act to have a material impact on its tax ~~expense upon final adoption~~expense. In Germany, the Company was approved for a deferral of corporate income tax payments for 2020. The Company will continue to monitor global legislative and regulatory developments related to COVID-19 and will ~~evaluate~~record the ~~impact of final guidance once it is released.~~

On June 14, 2019, the US Treasury released proposed and final regulations clarifying the GILTI inclusion and temporary and proposed regulations clarifying the dividends received deduction for foreign dividends paid to the US that were enactedassociated tax impacts as ~~part of the TCJA. The Company currently does not expect these regulations to have a material impact on tax expense and will evaluate the impact of further guidance as it is released.~~

During the three months ended September 30, 2019, the US Treasury released proposed regulations related to bonus depreciation, net operating loss limitations and revenue recognition rules for advanced payments. The Company does not expect these regulations to have a material impact on its tax expense and will evaluate the impact of further guidance as it is released.

In connection with the Company's US federal income tax audit for 2009 and 2010, the Company entered into a closing agreement during the three months ended March 31, 2019, which did not impact any previously recorded amounts based on settlement discussions prior to the formal closing agreement.

~~In January 2018, the Company received proposed pre-tax adjustments for its 2011 and 2012 audit cycle~~discrete events in the ~~amount of $198 million. In the event~~periods that guidance is finalized or the Company is ~~wholly unsuccessful in its defense~~able to estimate an impact.

The Company's 2013 through 2015 tax years are under joint examination by the US, German and ~~absent expected offsetting adjustments from foreign tax authorities, the proposed adjustments would result~~Dutch taxing authorities. The examinations are in the consumption of approximately $69 million of prior foreign tax credit carryforwards, which are substantially offset with a valuation allowance due to uncertain recoverability. The Company believes these proposed adjustments to be without merit and is vigorously defending its position.preliminary data gathering phase.

~~16. Leases~~

The Company leases certain real estate, fleet assets, warehouses and equipment. Leases with an initial term of 12 months or less ("short-term leases") are not recorded on the unaudited consolidated balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company determines if an arrangement is a lease at inception.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company's leases do not provide an implicit rate of return, the Company uses its imputed collateralized rate based on the information available at commencement date in determining the present value of lease payments. Operating lease ROU assets are comprised of the lease liability plus prepaid rents and are reduced by lease incentives or deferred rents. The Company has lease agreements with non-lease components which are not bifurcated.

Most leases include one or more options to renew, with renewal terms that can extend the lease term from one to 30 years. The exercise of a lease renewal option typically occurs at the discretion of both parties. Certain leases also include options to purchase the leased property. For purposes of calculating operating lease liabilities, lease terms are deemed not to include options to extend the lease termination until it is reasonably certain that the Company will exercise that option. Certain of the Company's lease agreements include payments adjusted periodically for inflation based on the consumer price index. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants.

~~Table of Contents~~

~~The components of lease expense are as follows:~~

Three Months Ended
September 30, Nine Months Ended
September 30, Statement of Operations Classification
2019
(In $ millions)
Lease Cost
Operating lease cost 10
30
Cost of sales / Selling, general and administrative expenses
Short-term lease cost 6
16
Cost of sales / Selling, general and administrative expenses
Variable lease cost 2
6
Cost of sales / Selling, general and administrative expenses
Finance lease cost
Amortization of leased assets 5
14
Cost of sales
Interest on lease liabilities 4
14
Interest expense
Sublease income —
—
Other income (expense), net
Total net lease cost 27
80

~~Supplemental unaudited consolidated balance sheet information related to leases is as follows:~~



	As of September 30, 2019	~~Balance Sheet Classification~~
	~~(In $ millions)~~
~~Leases~~
~~Assets~~
~~Operating lease assets~~	~~206~~	~~Operating lease ROU assets~~
~~Finance lease assets~~	87	~~Property, plant and equipment, net~~
~~Total leased assets~~	~~293~~

~~Liabilities~~
~~Current~~
~~Operating~~	31	~~Current Other liabilities~~
~~Finance~~	24	~~Short-term borrowings and current installments of long-term debt~~
~~Noncurrent~~
~~Operating~~	~~182~~	~~Operating lease liabilities~~
~~Finance~~	~~122~~	~~Long-term debt~~
~~Total lease liabilities~~	~~359~~



	As of September 30, 2019
~~Weighted-Average Remaining Lease Term (years)~~
~~Operating leases~~	~~14.9~~
~~Finance leases~~	~~7.0~~

~~Weighted-Average Discount Rate~~
~~Operating leases~~	~~2.7~~	%
~~Finance leases~~	~~11.6~~	%

~~Table of Contents~~

~~Supplemental unaudited interim consolidated cash flow information related to leases is as follows:~~



	Nine Months Ended September 30, 2019
	~~(In $ millions)~~
~~Cash paid for amounts included in the measurement of lease liabilities~~
~~Operating cash flows from operating leases~~	28
~~Operating cash flows from finance leases~~	15
~~Financing cash flows from finance leases~~	17

~~ROU assets obtained in exchange for finance lease liabilities~~	—
~~ROU assets obtained in exchange for operating lease liabilities~~	9

~~Maturities of lease liabilities are as follows:~~

As of September 30, 2019
Operating Leases Finance Leases
(In $ millions)
2019 10
11
2020 34
40
2021 26
39
2022 23
30
2023 20
22
Later years 146
86
Sublease income —
—
Total lease payments 259
228
Less amounts representing interest (46 ) (82 )
Total lease obligations 213
146

~~As of September 30, 2019, there were no additional operating or financing lease commitments that have not yet commenced.~~

~~Disclosures related to periods prior to adoption of ASU 2016-02~~

Operating lease rent expense was approximately $96 million for the year ended December 31, 2018. Future minimum lease payments under non-cancelable rental and lease agreements which had initial or remaining terms in excess of one year are as follows:

As of December 31, 2018
Operating Leases Capital Leases
(In $ millions)
2019 43
42
2020 34
42
2021 25
40
2022 23
32
2023 21
23
Later years 130
88
Sublease income —
—
Minimum lease commitments 276
267
Less amounts representing interest (100 )
Present value of net minimum lease obligations

167

~~Table of Contents~~

~~17.~~14. Derivative Financial Instruments

Derivatives Designated As Hedges

Net Investment Hedges

The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:

As of
September 30,
2019 As of
December 31,
2018
(In € millions)
Total 1,478
1,550



	As of June 30, 2020	As of December 31, 2019
	(In € millions)
Total	1,478	1,578

Cash Flow Hedges

The total notional amount of the forward-starting interest rate swap designated as a cash flow hedge is as follows:

As of
September 30,
2019 As of
December 31,
2018
(In $ millions)
Total 400
400



	As of June 30, 2020	As of December 31, 2019
	(In $ millions)
Total	400	400

Derivatives Not Designated As Hedges

Foreign Currency Forwards and Swaps

Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:

As of
September 30,
2019 As of
December 31,
2018
(In $ millions)
Total 803
1,071



	As of June 30, 2020	As of December 31, 2019
	(In $ millions)
Total	627	692

2722

Table of Contents

Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:


	Gain (Loss) Recognized in Other Comprehensive Income (Loss)			Gain (Loss) Recognized in Earnings (Loss)				Gain (Loss) Recognized in Other Comprehensive Income (Loss)				Gain (Loss) Recognized in Earnings (Loss)
	Three Months Ended September 30,						Statement of Operations Classification	Three Months Ended June 30,							Statement of Operations Classification
	2019		2018	2019	2018		Statement of Operations Classification	2020		2019		2020		2019	Statement of Operations Classification
	(In $ millions)							(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps	(13	)	2	1	—		Cost of sales	3		(2	)	—		2	Cost of sales
Interest rate swaps	(19	)	2	—	—		Interest expense	(2	)	(15	)	—		—	Interest expense
Total	(32	)	4	1	—			1		(17	)	—		2

Designated as Net Investment Hedges
Foreign currency denominated debt (Note 10)	48		9	—	—		N/A
Cross-currency swaps (Note 10)	22		—	—	—		N/A
Foreign currency denominated debt (Note 8)								(22	)	(13	)	—		—	N/A
Cross-currency swaps								(8	)	(6	)	—		—	N/A
Total	70		9	—	—			(30	)	(19	)	—		—

Not Designated as Hedges
Foreign currency forwards and swaps	—		—	9	(2	)	Foreign exchange gain (loss), net; Other income (expense), net	—		—		(1	)	3	Foreign exchange gain (loss), net; Other income (expense), net
Total	—		—	9	(2	)		—		—		(1	)	3


	Gain (Loss) Recognized in Other Comprehensive Income (Loss)			Gain (Loss) Recognized in Earnings (Loss)			Gain (Loss) Recognized in Other Comprehensive Income (Loss)				Gain (Loss) Recognized in Earnings (Loss)
	Nine Months Ended September 30,					Statement of Operations Classification	Six Months Ended June 30,						Statement of Operations Classification
	2019		2018	2019	2018	Statement of Operations Classification	2020		2019		2020	2019	Statement of Operations Classification
	(In $ millions)						(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps	(5	)	6	5	1	Cost of sales	3		8		—	4	Cost of sales
Interest rate swaps	(45	)	2	—	—	Interest expense	(53	)	(26	)	—	—	Interest expense
Foreign currency forwards	—		1	—	—	Cost of sales
Total	(50	)	9	5	1		(50	)	(18	)	—	4

Designated as Net Investment Hedges
Foreign currency denominated debt (Note 10)	74		44	—	—	N/A
Cross-currency swaps (Note 10)	16		—	—	—	N/A
Foreign currency denominated debt (Note 8)							15		26		—	—	N/A
Cross-currency swaps							22		(6	)	—	—	N/A
Total	90		44	—	—		37		20		—	—

Not Designated as Hedges
Foreign currency forwards and swaps	—		—	9	15	Foreign exchange gain (loss), net; Other income (expense), net	—		—		18	—	Foreign exchange gain (loss), net; Other income (expense), net
Total	—		—	9	15		—		—		18	—

See Note 1815 for additional information regarding the fair value of the Company's derivative instruments.

Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.

2823

Table of Contents

Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Derivative Assets
Gross amount recognized	28	11	39	16
Gross amount offset in the consolidated balance sheets	2	2	5	1
Net amount presented in the consolidated balance sheets	26	9	34	15
Gross amount not offset in the consolidated balance sheets	1	3	1	8
Net amount	25	6	33	7


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(In $ millions)		(In $ millions)
Derivative Liabilities
Gross amount recognized	70	20	105	59
Gross amount offset in the consolidated balance sheets	2	2	5	1
Net amount presented in the consolidated balance sheets	68	18	100	58
Gross amount not offset in the consolidated balance sheets	1	3	1	8
Net amount	67	15	99	50

~~18.~~15. Fair Value Measurements

The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:

Derivatives. Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.

2924

Table of Contents


	Fair Value Measurement						Fair Value Measurement
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)		Total		Balance Sheet Classification	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)		Total		Balance Sheet Classification
	(In $ millions)						(In $ millions)
As of September 30, 2019
As of June 30, 2020
Derivatives Designated as Cash Flow Hedges
Commodity swaps							—	1		1		Current Other assets
Designated as Net Investment Hedges
Cross-currency swaps							—	13		13		Current Other assets
Cross-currency swaps	—	16		16		Noncurrent Other assets	—	15		15		Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps	—	10		10		Current Other assets	—	5		5		Current Other assets
Total assets	—	26		26			—	34		34
Derivatives Designated as Cash Flow Hedges
Interest rate swaps	—	(55	)	(55	)	Noncurrent Other liabilities	—	(93	)	(93	)	Current Other liabilities
Commodity swaps	—	(6	)	(6	)	Current Other liabilities	—	(1	)	(1	)	Current Other liabilities
Commodity swaps	—	(3	)	(3	)	Noncurrent Other liabilities	—	(3	)	(3	)	Noncurrent Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps	—	(2	)	(2	)	Current Other liabilities	—	(1	)	(1	)	Current Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps	—	(2	)	(2	)	Current Other liabilities	—	(2	)	(2	)	Current Other liabilities
Total liabilities	—	(68	)	(68	)		—	(100	)	(100	)
As of December 31, 2018
Derivatives Designated as Cash Flow Hedges
Commodity swaps	—	1		1		Current Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps	—	8		8		Current Other assets
Total assets	—	9		9
Derivatives Designated as Cash Flow Hedges
Commodity swaps	—	(1	)	(1	)	Noncurrent Other liabilities
Interest rate swaps	—	(10	)	(10	)	Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps	—	(7	)	(7	)	Current Other liabilities
Total liabilities	—	(18	)	(18	)



	Fair Value Measurement
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)		Total		Balance Sheet Classification
	(In $ millions)
As of December 31, 2019
Derivatives Designated as Net Investment Hedges
Cross-currency swaps	—	13		13		Current Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps	—	2		2		Current Other assets
Total assets	—	15		15
Derivatives Designated as Cash Flow Hedges
Interest rate swaps	—	(40	)	(40	)	Noncurrent Other liabilities
Commodity swaps	—	(4	)	(4	)	Current Other liabilities
Commodity swaps	—	(3	)	(3	)	Noncurrent Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps	—	(1	)	(1	)	Current Other liabilities
Cross-currency swaps	—	(7	)	(7	)	Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps	—	(3	)	(3	)	Current Other liabilities
Total liabilities	—	(58	)	(58	)

3025

Table of Contents

Carrying values and fair values of financial instruments that are not carried at fair value are as follows:


		Fair Value Measurement				Fair Value Measurement
	Carrying Amount	Significant Other Observable Inputs (Level 2)	Unobservable Inputs (Level 3)	Total	Carrying Amount	Significant Other Observable Inputs (Level 2)	Unobservable Inputs (Level 3)	Total
	(In $ millions)				(In $ millions)
As of September 30, 2019
As of June 30, 2020
Equity investments without readily determinable fair values	170	—	—	—	170	—	—	—
Insurance contracts in nonqualified trusts	35	35	—	35	36	36	—	36
Long-term debt, including current installments of long-term debt	3,404	3,420	146	3,566	3,433	3,380	128	3,508
As of December 31, 2018
As of December 31, 2019
Equity investments without readily determinable fair values	164	—	—	—	170	—	—	—
Insurance contracts in nonqualified trusts	37	37	—	37	35	35	—	35
Long-term debt, including current installments of long-term debt	3,355	3,204	167	3,371	3,455	3,456	144	3,600

In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.

As of ~~September~~June 30, ~~2019,~~2020, and December 31, ~~2018,~~2019, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.

~~19.~~16. Commitments and Contingencies

Commitments

Guarantees

The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations. The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:

Demerger Obligations

In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 1210).

The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of ~~September~~June 30, ~~2019~~2020, are ~~$91~~$94 million. Though the Company is significantly under its

3126

Table of Contents

~~under its~~ obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.

The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.

Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.

Divestiture Obligations

The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 1210).

The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of ~~September~~June 30, ~~2019.~~2020. Other agreements do not provide for any monetary or time limitations.

Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.

Purchase Obligations

In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of ~~September~~June 30, ~~2019,~~2020, the Company had unconditional purchase obligations of ~~$1.2~~$2.5 billion, which extend through 2036.

Contingencies

The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition compliance, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy stockholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.

European Commission Investigation

In May 2017, the Company learned that the European Commission had opened a competition law investigation involving certain subsidiaries of the Company with respect to certain past ethylene purchases. ~~The Company is cooperating~~Based on information learned from the European Commission regarding its investigation, Celanese recorded a reserve of $89 million in 2019, which was included within the Company's Other Activities segment. On July 14, 2020, Celanese reached a final settlement with the European ~~Commission. Because the investigation is on-going, and the many uncertainties and variables involved, the Company is unable at this time to determine the outcome~~Commission in respect of this ~~investigation and whether, and in what amount, any potential fines would be assessed.~~matter of $92 million.

3227

Table of Contents

~~20.~~17. Segment Information


	Engineered Materials		Acetate Tow		Acetyl Chain	Other Activities		Eliminations			Consolidated			Engineered Materials		Acetate Tow		Acetyl Chain		Other Activities		Eliminations			Consolidated
	(In $ millions)													(In $ millions)
	Three Months Ended September 30, 2019													Three Months Ended June 30, 2020
Net sales	591		158		867	—		(30	)	⁽¹⁾	1,586			420		127		662		—		(16	)	⁽¹⁾	1,193
Other (charges) gains, net (Note 14)	(1	)	(3	)	—	(3	)	—			(7	)
Other (charges) gains, net (Note 12)														(25	)	—		5		(1	)	—			(21	)
Operating profit (loss)	111		34		180	(65	)	—			260			(13	)	31		121		(56	)	—			83
Equity in net earnings (loss) of affiliates	41		—		1	3		—			45			26		—		—		5		—			31
Depreciation and amortization	33		14		43	4		—			94			32		9		42		4		—			87
Capital expenditures	23		9		47	8		—			87		⁽²⁾	28		6		38		8		—			80		⁽²⁾
	Three Months Ended September 30, 2018													Three Months Ended June 30, 2019
Net sales	642		158		1,006	—		(35	)	⁽¹⁾	1,771			593		164		865		—		(30	)	⁽¹⁾	1,592
Other (charges) gains, net (Note 14)	—		(1	)	12	1		—			12
Other (charges) gains, net (Note 12)														(8	)	(84	)	(1	)	(5	)	—			(98	)
Operating profit (loss)	124		26		287	(63	)	—			374			103		(44	)	188		(61	)	—			186
Equity in net earnings (loss) of affiliates	62		—		2	2		—			66			36		—		1		2		—			39
Depreciation and amortization	31		21		36	2		—			90			31		11		38		4		—			84
Capital expenditures	25		9		39	2		—			75		⁽²⁾	21		11		35		7		—			74		⁽²⁾

______________________________


⁽¹⁾	Includes intersegment sales primarily related to the Acetyl Chain.


⁽²⁾	Includes ~~an increase~~a decrease in accrued capital expenditures of $5$8 million and ~~a decrease~~an increase of $4$9 million for the three months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~,2019, respectively.

3328

Table of Contents


	Engineered Materials	Acetate Tow		Acetyl Chain		Other Activities		Eliminations			Consolidated			Engineered Materials		Acetate Tow		Acetyl Chain		Other Activities		Eliminations			Consolidated
	(In $ millions)													(In $ millions)
	Nine Months Ended September 30, 2019													Six Months Ended June 30, 2020
Net sales	1,847	488		2,621		—		(91	)	⁽¹⁾	4,865			983		256		1,461		—		(47	)	⁽¹⁾	2,653
Other (charges) gains, net (Note 14)	6	(87	)	(1	)	(19	)	—			(101	)
Other (charges) gains, net (Note 12)														(25	)	(1	)	5		(6	)	—			(27	)
Operating profit (loss)	358	30		570		(192	)	—			766			89		58		256		(126	)	—			277
Equity in net earnings (loss) of affiliates	123	—		3		8		—			134			79		—		1		8		—			88
Depreciation and amortization	96	35		119		11		—			261			66		17		81		8		—			172
Capital expenditures	60	28		108		19		—			215		⁽²⁾	52		16		81		17		—			166		⁽²⁾
	As of September 30, 2019													As of June 30, 2020
Goodwill and intangible assets, net	988	152		228		—		—			1,368			985		152		278		—		—			1,415
Total assets	4,081	967		3,448		918		—			9,414			4,009		939		3,549		1,009		—			9,506
	Nine Months Ended September 30, 2018													Six Months Ended June 30, 2019
Net sales	1,971	488		3,106		—		(99	)	⁽¹⁾	5,466			1,256		330		1,754		—		(61	)	⁽¹⁾	3,279
Other (charges) gains, net (Note 14)	—	(2	)	10		1		—			9
Other (charges) gains, net (Note 12)														7		(84	)	(1	)	(16	)	—			(94	)
Operating profit (loss)	365	111		813		(214	)	—			1,075			247		(4	)	390		(127	)	—			506
Equity in net earnings (loss) of affiliates	169	—		5		6		—			180			82		—		2		5		—			89
Depreciation and amortization	96	44		107		8		—			255			63		21		76		7		—			167
Capital expenditures	72	19		122		7		—			220		⁽²⁾	37		19		61		11		—			128		⁽²⁾
	As of December 31, 2018													As of December 31, 2019
Goodwill and intangible assets, net	974	153		240		—		—			1,367			999		153		234		—		—			1,386
Total assets	4,012	1,032		3,471		798		—			9,313			4,125		977		3,489		885		—			9,476

______________________________


⁽¹⁾	Includes intersegment sales primarily related to the Acetyl Chain.


⁽²⁾	Includes a decrease in accrued capital expenditures of ~~$11~~$41 million and ~~$24~~$16 million for the ~~nine~~six months ended ~~September~~June 30, 2020 and 2019, ~~and~~ ~~2018~~, respectively.

~~21.~~18. Revenue Recognition

The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of ~~September~~June 30, ~~2019,~~2020, the Company had ~~$666~~$619 million of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately ~~$87~~$99 million of its remaining performance obligations as Net sales in ~~2019, $197~~2020, $186 million in ~~2020, $151~~2021, $126 million in ~~2021~~2022 and the balance thereafter.

Contract Balances

Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Noncurrent Other liabilities in the unaudited consolidated balance sheets (Note 97).

The Company does not have any material contract assets as of ~~September~~June 30, ~~2019.~~2020.

Disaggregated Revenue

In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.

The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customers' unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.

3429

Table of Contents

Within the Acetate Tow business segment, the Company's primary product is acetate tow, which is managed through contracts with a few major tobacco companies and accounts for a significant amount of filters used in cigarette production worldwide.

The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its emulsion polymers business. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.

Further disaggregation of Net sales by business segment and geographic destination is as follows:


	Three Months Ended September 30,		Nine Months Ended September 30,		Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018	2020	2019	2020	2019
	(In $ millions)				(In $ millions)
Engineered Materials
North America	195	197	571	567	111	180	273	376
Europe and Africa	251	277	822	945	183	269	443	571
Asia-Pacific	126	145	400	403	117	126	240	274
South America	19	23	54	56	9	18	27	35
Total	591	642	1,847	1,971	420	593	983	1,256

Acetate Tow
North America	30	30	97	98	27	33	48	67
Europe and Africa	63	78	193	196	68	67	139	130
Asia-Pacific	60	44	176	163	29	56	61	116
South America	5	6	22	31	3	8	8	17
Total	158	158	488	488	127	164	256	330

Acetyl Chain
North America	273	298	837	873	208	278	482	564
Europe and Africa	280	302	856	958	236	282	502	576
Asia-Pacific	264	341	772	1,081	190	252	397	508
South America	20	30	65	95	12	23	33	45
Total⁽¹⁾	837	971	2,530	3,007	646	835	1,414	1,693

______________________________


⁽¹⁾	Excludes intersegment sales of ~~$30~~$16 million and ~~$35~~$30 million for the three months ended ~~September~~June 30, ~~2019~~2020 and ~~2018,~~2019, respectively. Excludes intersegment sales of ~~$91~~$47 million and ~~$99~~$61 million for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018,~~2019, respectively.

~~22. Earnings (Loss) Per Share~~

Three Months Ended
September 30, Nine Months Ended
September 30,
2019 2018 2019 2018
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations 268
407
816
1,116
Earnings (loss) from discontinued operations (5 ) (6 ) (7 ) (8 )
Net earnings (loss) 263
401
809
1,108

Weighted average shares - basic 122,699,859
134,519,301
125,159,647
135,336,704
Incremental shares attributable to equity awards 599,805
980,089

709,182
1,050,999
Weighted average shares - diluted 123,299,664
135,499,390
125,868,829
136,387,703

3530

Table of Contents

~~During the three and nine months ended September 30, 2019 and 2018, there were no anti-dilutive equity awards excluded from the computation of diluted net earnings per share.~~19. Earnings (Loss) Per Share



	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
	(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations	110		210		335		548
Earnings (loss) from discontinued operations	(3	)	(1	)	(10	)	(2	)
Net earnings (loss)	107		209		325		546

Weighted average shares - basic	118,339,872		125,289,967		118,795,780		126,409,926
Incremental shares attributable to equity awards⁽¹⁾	427,761		557,927		581,735		701,120
Weighted average shares - diluted	118,767,633		125,847,894		119,377,515		127,111,046

______________________________


⁽¹⁾	Excludes 120,210 and 0 equity award shares for the three months ended June 30, 2020 and 2019, respectively, as their effect would have been antidilutive. Excludes 89,241 and 0 equity award shares for the six months ended June 30, 2020 and 2019, respectively, as their effect would have been antidilutive.

~~23.~~20. Consolidating Guarantor Financial Information

The Senior Notes were issued by Celanese US ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (Note 108). The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Parent Guarantor and Subsidiary Guarantors have guaranteed the Notes fully and unconditionally and jointly and severally.

For cash management purposes, the Company transfers cash between the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company's outstanding debt, Common Stock dividends and Common Stock repurchases. The unaudited interim consolidating statements of cash flows for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 and ~~2018~~2019 present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows.

The Company has not presented separate financial information and other disclosures for each of its Subsidiary Guarantors because it believes such financial information and other disclosures would not provide investors with any additional information that would be material in evaluating the sufficiency of the guarantees.

The unaudited interim consolidating financial statements for the Parent Guarantor, the Issuer, the Subsidiary Guarantors and the non-guarantors are as follows:

3631

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENT OF OPERATIONS


	Three Months Ended September 30, 2019												Three Months Ended June 30, 2020
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net sales	—		—		570		1,292		(276	)	1,586		—		—		462		1,033		(302	)	1,193
Cost of sales	—		—		(444	)	(1,011	)	283		(1,172	)	—		—		(408	)	(822	)	279		(951	)
Gross profit	—		—		126		281		7		414		—		—		54		211		(23	)	242
Selling, general and administrative expenses	—		—		(46	)	(74	)	—		(120	)	—		—		(36	)	(78	)	—		(114	)
Amortization of intangible assets	—		—		(2	)	(4	)	—		(6	)	—		—		(2	)	(4	)	—		(6	)
Research and development expenses	—		—		(7	)	(10	)	—		(17	)	—		—		(8	)	(10	)	—		(18	)
Other (charges) gains, net	—		—		(1	)	(6	)	—		(7	)	—		—		(5	)	(16	)	—		(21	)
Foreign exchange gain (loss), net	—		—		—		(1	)	—		(1	)	—		—		—		1		—		1
Gain (loss) on disposition of businesses and assets, net	—		—		(3	)	—		—		(3	)	—		—		(2	)	1		—		(1	)
Operating profit (loss)	—		—		67		186		7		260		—		—		1		105		(23	)	83
Equity in net earnings (loss) of affiliates	277		267		183		43		(725	)	45		110		111		137		29		(356	)	31
Non-operating pension and other postretirement employee benefit (expense) income	—		—		15		2		—		17		—		—		25		2		—		27
Interest expense	(20	)	(5	)	(37	)	(9	)	44		(27	)	(4	)	(10	)	(25	)	(3	)	15		(27	)
Interest income	—		18		23		4		(44	)	1		—		9		5		2		(15	)	1
Dividend income - equity investments	—		—		—		27		—		27		—		—		—		32		—		32
Other income (expense), net	—		—		1		(1	)	—		—		—		(1	)	(1	)	2		—		—
Earnings (loss) from continuing operations before tax	257		280		252		252		(718	)	323		106		109		142		169		(379	)	147
Income tax (provision) benefit	6		(3	)	2		(57	)	(1	)	(53	)	1		1		(23	)	(17	)	3		(35	)
Earnings (loss) from continuing operations	263		277		254		195		(719	)	270		107		110		119		152		(376	)	112
Earnings (loss) from operation of discontinued operations	—		—		(6	)	—		—		(6	)	—		—		(4	)	—		—		(4	)
Income tax (provision) benefit from discontinued operations	—		—		1		—		—		1		—		—		1		—		—		1
Earnings (loss) from discontinued operations	—		—		(5	)	—		—		(5	)	—		—		(3	)	—		—		(3	)
Net earnings (loss)	263		277		249		195		(719	)	265		107		110		116		152		(376	)	109
Net (earnings) loss attributable to noncontrolling interests	—		—		—		(2	)	—		(2	)	—		—		—		(2	)	—		(2	)
Net earnings (loss) attributable to Celanese Corporation	263		277		249		193		(719	)	263		107		110		116		150		(376	)	107

3732

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENT OF OPERATIONS


	Three Months Ended September 30, 2018											Three Months Ended June 30, 2019
	Parent Guarantor	Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor	Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)											(In $ millions)
Net sales	—	—		565		1,483		(277	)	1,771		—	—		586		1,298		(292	)	1,592
Cost of sales	—	—		(432	)	(1,105	)	282		(1,255	)	—	—		(443	)	(1,020	)	294		(1,169	)
Gross profit	—	—		133		378		5		516		—	—		143		278		2		423
Selling, general and administrative expenses	—	—		(46	)	(83	)	—		(129	)	—	—		(39	)	(79	)	—		(118	)
Amortization of intangible assets	—	—		(1	)	(4	)	—		(5	)	—	—		(2	)	(4	)	—		(6	)
Research and development expenses	—	—		(7	)	(11	)	—		(18	)	—	—		(7	)	(10	)	—		(17	)
Other (charges) gains, net	—	—		—		12		—		12		—	—		(5	)	(93	)	—		(98	)
Foreign exchange gain (loss), net	—	(3	)	—		3		—		—		—	—		—		1		—		1
Gain (loss) on disposition of businesses and assets, net	—	—		(3	)	1		—		(2	)	—	—		(2	)	3		—		1
Operating profit (loss)	—	(3	)	76		296		5		374		—	—		88		96		2		186
Equity in net earnings (loss) of affiliates	401	411		286		64		(1,096	)	66		209	210		122		34		(536	)	39
Non-operating pension and other postretirement employee benefit (expense) income	—	—		23		3		(1	)	25		—	—		16		1		—		17
Interest expense	—	(5	)	(33	)	(8	)	16		(30	)	—	(9	)	(35	)	(13	)	28		(29	)
Refinancing expense												—	(4	)	—		—		—		(4	)
Interest income	—	13		1		3		(15	)	2		—	18		11		1		(28	)	2
Dividend income - equity investments	—	—		—		25		1		26		—	—		—		30		—		30
Other income (expense), net	—	—		1		(1	)	(1	)	(1	)	—	(4	)	—		2		—		(2	)
Earnings (loss) from continuing operations before tax	401	416		354		382		(1,091	)	462		209	211		202		151		(534	)	239
Income tax (provision) benefit	—	(15	)	(10	)	(28	)	(1	)	(54	)	—	(2	)	(23	)	(3	)	—		(28	)
Earnings (loss) from continuing operations	401	401		344		354		(1,092	)	408		209	209		179		148		(534	)	211
Earnings (loss) from operation of discontinued operations	—	—		(1	)	(6	)	—		(7	)	—	—		(2	)	—		—		(2	)
Income tax (provision) benefit from discontinued operations	—	—		—		1		—		1		—	—		1		—		—		1
Earnings (loss) from discontinued operations	—	—		(1	)	(5	)	—		(6	)	—	—		(1	)	—		—		(1	)
Net earnings (loss)	401	401		343		349		(1,092	)	402		209	209		178		148		(534	)	210
Net (earnings) loss attributable to noncontrolling interests	—	—		—		(1	)	—		(1	)	—	—		—		(1	)	—		(1	)
Net earnings (loss) attributable to Celanese Corporation	401	401		343		348		(1,092	)	401		209	209		178		147		(534	)	209

3833

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENT OF OPERATIONS


	Nine Months Ended September 30, 2019												Six Months Ended June 30, 2020
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net sales	—		—		1,780		3,963		(878	)	4,865		—		—		1,022		2,236		(605	)	2,653
Cost of sales	—		—		(1,345	)	(3,108	)	878		(3,575	)	—		—		(868	)	(1,768	)	573		(2,063	)
Gross profit	—		—		435		855		—		1,290		—		—		154		468		(32	)	590
Selling, general and administrative expenses	—		—		(125	)	(233	)	—		(358	)	—		—		(90	)	(149	)	—		(239	)
Amortization of intangible assets	—		—		(6	)	(12	)	—		(18	)	—		—		(4	)	(7	)	—		(11	)
Research and development expenses	—		—		(20	)	(30	)	—		(50	)	—		—		(15	)	(20	)	—		(35	)
Other (charges) gains, net	—		—		(6	)	(95	)	—		(101	)	—		—		(13	)	(14	)	—		(27	)
Foreign exchange gain (loss), net	—		—		—		5		—		5		—		—		(1	)	1		—		—
Gain (loss) on disposition of businesses and assets, net	—		—		(7	)	5		—		(2	)	—		—		(4	)	3		—		(1	)
Operating profit (loss)	—		—		271		495		—		766		—		—		27		282		(32	)	277
Equity in net earnings (loss) of affiliates	823		814		522		120		(2,145	)	134		336		333		325		80		(986	)	88
Non-operating pension and other postretirement employee benefit (expense) income	—		—		46		5		—		51		—		—		50		5		—		55
Interest expense	(20	)	(24	)	(103	)	(29	)	89		(87	)	(12	)	(19	)	(55	)	(8	)	39		(55	)
Refinancing expense	—		(4	)	—		—		—		(4	)
Interest income	—		49		36		8		(89	)	4		—		22		15		6		(40	)	3
Dividend income - equity investments	—		—		—		89		—		89		—		—		—		68		1		69
Other income (expense), net	—		(3	)	1		(4	)	—		(6	)	—		7		—		(5	)	—		2
Earnings (loss) from continuing operations before tax	803		832		773		684		(2,145	)	947		324		343		362		428		(1,018	)	439
Income tax (provision) benefit	6		(9	)	(28	)	(96	)	—		(127	)	1		(7	)	(18	)	(80	)	4		(100	)
Earnings (loss) from continuing operations	809		823		745		588		(2,145	)	820		325		336		344		348		(1,014	)	339
Earnings (loss) from operation of discontinued operations	—		—		(9	)	—		—		(9	)	—		—		(4	)	(7	)	—		(11	)
Income tax (provision) benefit from discontinued operations	—		—		2		—		—		2		—		—		1		—		—		1
Earnings (loss) from discontinued operations	—		—		(7	)	—		—		(7	)	—		—		(3	)	(7	)	—		(10	)
Net earnings (loss)	809		823		738		588		(2,145	)	813		325		336		341		341		(1,014	)	329
Net (earnings) loss attributable to noncontrolling interests	—		—		—		(4	)	—		(4	)	—		—		—		(4	)	—		(4	)
Net earnings (loss) attributable to Celanese Corporation	809		823		738		584		(2,145	)	809		325		336		341		337		(1,014	)	325

3934

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENT OF OPERATIONS


	Nine Months Ended September 30, 2018											Six Months Ended June 30, 2019
	Parent Guarantor	Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor	Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)											(In $ millions)
Net sales	—	—		1,733		4,621		(888	)	5,466		—	—		1,210		2,671		(602	)	3,279
Cost of sales	—	—		(1,337	)	(3,470	)	893		(3,914	)	—	—		(901	)	(2,097	)	595		(2,403	)
Gross profit	—	—		396		1,151		5		1,552		—	—		309		574		(7	)	876
Selling, general and administrative expenses	—	—		(156	)	(256	)	—		(412	)	—	—		(79	)	(159	)	—		(238	)
Amortization of intangible assets	—	—		(3	)	(15	)	—		(18	)	—	—		(4	)	(8	)	—		(12	)
Research and development expenses	—	—		(22	)	(32	)	—		(54	)	—	—		(13	)	(20	)	—		(33	)
Other (charges) gains, net	—	—		—		9		—		9		—	—		(5	)	(89	)	—		(94	)
Foreign exchange gain (loss), net	—	(3	)	—		5		—		2		—	—		—		6		—		6
Gain (loss) on disposition of businesses and assets, net	—	—		(8	)	4		—		(4	)	—	—		(4	)	5		—		1
Operating profit (loss)	—	(3	)	207		866		5		1,075		—	—		204		309		(7	)	506
Equity in net earnings (loss) of affiliates	1,108	1,112		872		170		(3,082	)	180		546	547		339		77		(1,420	)	89
Non-operating pension and other postretirement employee benefit (expense) income	—	—		70		8		(1	)	77		—	—		31		3		—		34
Interest expense	—	(15	)	(93	)	(25	)	38		(95	)	—	(19	)	(66	)	(20	)	45		(60	)
Refinancing expense												—	(4	)	—		—		—		(4	)
Interest income	—	31		5		7		(39	)	4		—	31		13		4		(45	)	3
Dividend income - equity investments	—	—		—		89		3		92		—	—		—		62		—		62
Other income (expense), net	—	—		1		3		(1	)	3		—	(3	)	—		(3	)	—		(6	)
Earnings (loss) from continuing operations before tax	1,108	1,125		1,062		1,118		(3,077	)	1,336		546	552		521		432		(1,427	)	624
Income tax (provision) benefit	—	(17	)	(115	)	(83	)	(1	)	(216	)	—	(6	)	(30	)	(39	)	1		(74	)
Earnings (loss) from continuing operations	1,108	1,108		947		1,035		(3,078	)	1,120		546	546		491		393		(1,426	)	550
Earnings (loss) from operation of discontinued operations	—	—		(2	)	(7	)	—		(9	)	—	—		(3	)	—		—		(3	)
Income tax (provision) benefit from discontinued operations	—	—		—		1		—		1		—	—		1		—		—		1
Earnings (loss) from discontinued operations	—	—		(2	)	(6	)	—		(8	)	—	—		(2	)	—		—		(2	)
Net earnings (loss)	1,108	1,108		945		1,029		(3,078	)	1,112		546	546		489		393		(1,426	)	548
Net (earnings) loss attributable to noncontrolling interests	—	—		—		(4	)	—		(4	)	—	—		—		(2	)	—		(2	)
Net earnings (loss) attributable to Celanese Corporation	1,108	1,108		945		1,025		(3,078	)	1,108		546	546		489		391		(1,426	)	546

4035

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)


	Three Months Ended September 30, 2019												Three Months Ended June 30, 2020
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors	Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net earnings (loss)	263		277		249		195		(719	)	265		107		110		116	152		(376	)	109
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)	(7	)	(7	)	(52	)	(67	)	126		(7	)	(6	)	(6	)	15	18		(27	)	(6	)
Gain (loss) on cash flow hedges	(32	)	(32	)	(12	)	(12	)	56		(32	)	1		1		3	2		(6	)	1
Total other comprehensive income (loss), net of tax	(39	)	(39	)	(64	)	(79	)	182		(39	)	(5	)	(5	)	18	20		(33	)	(5	)
Total comprehensive income (loss), net of tax	224		238		185		116		(537	)	226		102		105		134	172		(409	)	104
Comprehensive (income) loss attributable to noncontrolling interests	—		—		—		(2	)	—		(2	)	—		—		—	(2	)	—		(2	)
Comprehensive income (loss) attributable to Celanese Corporation	224		238		185		114		(537	)	224		102		105		134	170		(409	)	102


	Three Months Ended September 30, 2018												Three Months Ended June 30, 2019
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net earnings (loss)	401		401		343		349		(1,092	)	402		209		209		178		148		(534	)	210
Other comprehensive income (loss), net of tax
Unrealized gain (loss) on marketable securities	—		—		1		—		(1	)	—
Foreign currency translation gain (loss)	(35	)	(35	)	(31	)	(37	)	103		(35	)	(11	)	(11	)	2		4		5		(11	)
Gain (loss) on cash flow hedges	4		4		2		2		(8	)	4		(13	)	(13	)	(3	)	(3	)	19		(13	)
Total other comprehensive income (loss), net of tax	(31	)	(31	)	(28	)	(35	)	94		(31	)	(24	)	(24	)	(1	)	1		24		(24	)
Total comprehensive income (loss), net of tax	370		370		315		314		(998	)	371		185		185		177		149		(510	)	186
Comprehensive (income) loss attributable to noncontrolling interests	—		—		—		(1	)	—		(1	)	—		—		—		(1	)	—		(1	)
Comprehensive income (loss) attributable to Celanese Corporation	370		370		315		313		(998	)	370		185		185		177		148		(510	)	185

4136

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)


	Nine Months Ended September 30, 2019												Six Months Ended June 30, 2020
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net earnings (loss)	809		823		738		588		(2,145	)	813		325		336		341		341		(1,014	)	329
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)	(11	)	(11	)	(68	)	(87	)	166		(11	)	(8	)	(8	)	(29	)	(36	)	73		(8	)
Gain (loss) on cash flow hedges	(48	)	(48	)	(9	)	(7	)	64		(48	)	(38	)	(38	)	2		2		34		(38	)
Total other comprehensive income (loss), net of tax	(59	)	(59	)	(77	)	(94	)	230		(59	)	(46	)	(46	)	(27	)	(34	)	107		(46	)
Total comprehensive income (loss), net of tax	750		764		661		494		(1,915	)	754		279		290		314		307		(907	)	283
Comprehensive (income) loss attributable to noncontrolling interests	—		—		—		(4	)	—		(4	)	—		—		—		(4	)	—		(4	)
Comprehensive income (loss) attributable to Celanese Corporation	750		764		661		490		(1,915	)	750		279		290		314		303		(907	)	279



	Six Months Ended June 30, 2019
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)
Net earnings (loss)	546		546		489		393		(1,426	)	548
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)	(4	)	(4	)	(16	)	(20	)	40		(4	)
Gain (loss) on cash flow hedges	(16	)	(16	)	3		5		8		(16	)
Total other comprehensive income (loss), net of tax	(20	)	(20	)	(13	)	(15	)	48		(20	)
Total comprehensive income (loss), net of tax	526		526		476		378		(1,378	)	528
Comprehensive (income) loss attributable to noncontrolling interests	—		—		—		(2	)	—		(2	)
Comprehensive income (loss) attributable to Celanese Corporation	526		526		476		376		(1,378	)	526

Nine Months Ended September 30, 2018

Parent
Guarantor
Issuer
Subsidiary
Guarantors

Non-
Guarantors
Eliminations Consolidated
(In $ millions)
Net earnings (loss) 1,108
1,108
945
1,029
(3,078 ) 1,112
Other comprehensive income (loss), net of tax
Unrealized gain (loss) on marketable securities —
—
6
13
(19 ) —
Foreign currency translation gain (loss) (52 ) (52 ) (77 ) (95 ) 224
(52 )
Gain (loss) on cash flow hedges 9
9
6
7
(22 ) 9
Pension and postretirement benefits gain (loss) 1
1
1
1
(3 ) 1
Total other comprehensive income (loss), net of tax (42 ) (42 ) (64 ) (74 ) 180
(42 )
Total comprehensive income (loss), net of tax 1,066
1,066
881
955
(2,898 ) 1,070
Comprehensive (income) loss attributable to noncontrolling interests —
—
—
(4 ) —
(4 )
Comprehensive income (loss) attributable to Celanese Corporation 1,066
1,066
881
951
(2,898 ) 1,066

4237

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATING BALANCE SHEET


	As of September 30, 2019							As of June 30, 2020
	Parent Guarantor	Issuer	Subsidiary Guarantors	Non- Guarantors	Eliminations		Consolidated	Parent Guarantor	Issuer	Subsidiary Guarantors	Non- Guarantors	Eliminations		Consolidated
	(In $ millions)							(In $ millions)
ASSETS
Current Assets
Cash and cash equivalents	—	—	87	410	—		497	—	—	28	511	—		539
Trade receivables - third party and affiliates	—	—	102	958	(113	)	947	—	—	146	732	(149	)	729
Non-trade receivables, net	46	1,082	1,771	705	(3,269	)	335	58	2,999	2,103	1,126	(5,974	)	312
Inventories, net	—	—	337	706	(49	)	994	—	—	381	729	(79	)	1,031
Marketable securities, at fair value	—	—	26	—	—		26
Marketable securities								—	—	21	15	—		36
Other assets	—	31	17	73	(77	)	44	—	25	27	38	(28	)	62
Total current assets	46	1,113	2,340	2,852	(3,508	)	2,843	58	3,024	2,706	3,151	(6,230	)	2,709
Investments in affiliates	4,006	5,135	4,241	839	(13,251	)	970	4,350	5,515	4,421	824	(14,153	)	957
Property, plant and equipment, net	—	—	1,373	2,212	—		3,585	—	—	1,501	2,224	—		3,725
Operating lease right-of-use assets	—	—	54	152	—		206	—	—	49	152	—		201
Deferred income taxes	—	—	—	100	(2	)	98	—	—	—	102	(2	)	100
Other assets	1	1,674	194	426	(1,951	)	344	—	22	228	159	(10	)	399
Goodwill	—	—	399	655	—		1,054	—	—	398	700	—		1,098
Intangible assets, net	—	—	127	187	—		314	—	—	121	196	—		317
Total assets	4,053	7,922	8,728	7,423	(18,712	)	9,414	4,408	8,561	9,424	7,508	(20,395	)	9,506
LIABILITIES AND EQUITY
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	1,280	251	914	555	(2,632	)	368	1,921	1,192	3,077	231	(5,376	)	1,045
Trade payables - third party and affiliates	25	1	295	556	(113	)	764	—	—	270	478	(149	)	599
Other liabilities	—	79	190	297	(208	)	358	—	136	169	392	(125	)	572
Income taxes payable	1	—	495	53	(506	)	43	—	—	475	76	(505	)	46
Total current liabilities	1,306	331	1,894	1,461	(3,459	)	1,533	1,921	1,328	3,991	1,177	(6,155	)	2,262
Noncurrent Liabilities
Long-term debt	—	3,502	1,678	104	(1,925	)	3,359	—	2,881	26	82	—		2,989
Deferred income taxes	—	26	84	161	(2	)	269	—	—	97	161	(2	)	256
Uncertain tax positions	—	2	6	161	—		169	—	2	—	174	13		189
Benefit obligations	—	—	237	286	—		523	—	—	248	331	—		579
Operating lease liabilities	—	—	43	139	—		182	—	—	40	143	—		183
Other liabilities	—	55	94	126	(35	)	240	—	—	93	119	(33	)	179
Total noncurrent liabilities	—	3,585	2,142	977	(1,962	)	4,742	—	2,883	504	1,010	(22	)	4,375
Total Celanese Corporation stockholders' equity	2,747	4,006	4,692	4,593	(13,291	)	2,747	2,487	4,350	4,929	4,939	(14,218	)	2,487
Noncontrolling interests	—	—	—	392	—		392	—	—	—	382	—		382
Total equity	2,747	4,006	4,692	4,985	(13,291	)	3,139	2,487	4,350	4,929	5,321	(14,218	)	2,869
Total liabilities and equity	4,053	7,922	8,728	7,423	(18,712	)	9,414	4,408	8,561	9,424	7,508	(20,395	)	9,506

4338

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATING BALANCE SHEET


	As of December 31, 2018							As of December 31, 2019
	Parent Guarantor	Issuer	Subsidiary Guarantors	Non- Guarantors	Eliminations		Consolidated	Parent Guarantor	Issuer	Subsidiary Guarantors	Non- Guarantors	Eliminations		Consolidated
	(In $ millions)							(In $ millions)
ASSETS
Current Assets
Cash and cash equivalents	—	—	30	409	—		439	—	—	16	447	—		463
Trade receivables - third party and affiliates	—	—	96	1,040	(119	)	1,017	—	—	122	851	(123	)	850
Non-trade receivables, net	40	551	797	697	(1,784	)	301	56	1,188	1,925	743	(3,581	)	331
Inventories, net	—	—	329	765	(48	)	1,046	—	—	360	725	(47	)	1,038
Marketable securities, at fair value	—	—	31	—	—		31
Marketable securities								—	—	24	16	—		40
Other assets	—	24	10	37	(31	)	40	—	36	11	38	(42	)	43
Total current assets	40	575	1,293	2,948	(1,982	)	2,874	56	1,224	2,458	2,820	(3,793	)	2,765
Investments in affiliates	3,503	4,820	4,678	855	(12,877	)	979	4,064	5,217	4,206	841	(13,353	)	975
Property, plant and equipment, net	—	—	1,289	2,430	—		3,719	—	—	1,461	2,252	—		3,713
Operating lease right-of-use assets								—	—	50	153	—		203
Deferred income taxes	—	—	—	86	(2	)	84	—	—	—	101	(5	)	96
Other assets	—	1,658	142	461	(1,971	)	290	—	1,661	195	445	(1,963	)	338
Goodwill	—	—	399	658	—		1,057	—	—	399	675	—		1,074
Intangible assets, net	—	—	132	178	—		310	—	—	125	187	—		312
Total assets	3,543	7,053	7,933	7,616	(16,832	)	9,313	4,120	8,102	8,894	7,474	(19,114	)	9,476
LIABILITIES AND EQUITY
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	544	333	465	258	(1,039	)	561	1,596	374	1,089	385	(2,948	)	496
Trade payables - third party and affiliates	13	1	342	583	(120	)	819	17	—	333	553	(123	)	780
Other liabilities	1	87	267	258	(270	)	343	—	49	188	397	(173	)	461
Income taxes payable	—	—	475	88	(507	)	56	—	—	439	80	(502	)	17
Total current liabilities	558	421	1,549	1,187	(1,936	)	1,779	1,613	423	2,049	1,415	(3,746	)	1,754
Noncurrent Liabilities
Long-term debt	—	3,104	1,679	127	(1,940	)	2,970	—	3,565	1,677	101	(1,934	)	3,409
Deferred income taxes	—	15	85	157	(2	)	255	—	3	101	158	(5	)	257
Uncertain tax positions	—	—	6	152	—		158	—	—	—	169	(4	)	165
Benefit obligations	—	—	250	314	—		564	—	—	257	332	—		589
Operating lease liabilities								—	—	40	140	1		181
Other liabilities	1	10	99	138	(40	)	208	—	47	93	118	(35	)	223
Total noncurrent liabilities	1	3,129	2,119	888	(1,982	)	4,155	—	3,615	2,168	1,018	(1,977	)	4,824
Total Celanese Corporation stockholders' equity	2,984	3,503	4,265	5,146	(12,914	)	2,984	2,507	4,064	4,677	4,650	(13,391	)	2,507
Noncontrolling interests	—	—	—	395	—		395	—	—	—	391	—		391
Total equity	2,984	3,503	4,265	5,541	(12,914	)	3,379	2,507	4,064	4,677	5,041	(13,391	)	2,898
Total liabilities and equity	3,543	7,053	7,933	7,616	(16,832	)	9,313	4,120	8,102	8,894	7,474	(19,114	)	9,476

4439

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENT OF CASH FLOWS


	Nine Months Ended September 30, 2019												Six Months Ended June 30, 2020
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net cash provided by (used in) operating activities	988		(47	)	1,132		616		(1,561	)	1,128		315		(339	)	256		406		—		638
Investing Activities
Capital expenditures on property, plant and equipment	—		—		(137	)	(89	)	—		(226	)	—		—		(127	)	(80	)	—		(207	)
Acquisitions, net of cash acquired	—		—		(31	)	(60	)	—		(91	)	—		—		(5	)	(83	)	—		(88	)
Proceeds from sale of businesses and assets, net	—		—		6		—		(5	)	1		—		—		—		3		—		3
Return of capital from subsidiary	—		—		7		—		(7	)	—		—		—		23		—		(23	)	—
Intercompany loan receipts (disbursements)	—		—		(649	)	—		649		—		—		—		(88	)	(67	)	155		—
Other, net	—		—		1		(15	)	5		(9	)	—		—		(8	)	(9	)	—		(17	)
Net cash provided by (used in) investing activities	—		—		(803	)	(164	)	642		(325	)	—		—		(205	)	(236	)	132		(309	)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less	—		165		4		(3	)	(39	)	127		—		(28	)	(17	)	—		(91	)	(136	)
Proceeds from short-term borrowings	—		—		—		720		(610	)	110		—		300		—		6		—		306
Repayments of short-term borrowings	—		—		—		(85	)	—		(85	)	—		—		—		(50	)	—		(50	)
Proceeds from long-term debt	—		499		—		—		—		499		—		339		—		—		(339	)	—
Repayments of long-term debt	—		(335	)	(1	)	(18	)	—		(354	)	—		(272	)	(2	)	(17	)	275		(16	)
Purchases of treasury stock, including related fees	(763	)	—		—		—		—		(763	)	(167	)	—		—		—		—		(167	)
Dividends to parent	—		(272	)	(251	)	(1,038	)	1,561		—
Common stock dividends	(225	)	—		—		—		—		(225	)	(148	)	—		—		—		—		(148	)
Return of capital to parent	—		—		—		(7	)	7		—		—		—		—		(23	)	23		—
(Distributions to) contributions from noncontrolling interests	—		—		—		(7	)	—		(7	)
Distributions to noncontrolling interests													—		—		—		(13	)	—		(13	)
Other, net	—		(10	)	(24	)	(4	)	—		(38	)	—		—		(20	)	(4	)	—		(24	)
Net cash provided by (used in) financing activities	(988	)	47		(272	)	(442	)	919		(736	)	(315	)	339		(39	)	(101	)	(132	)	(248	)
Exchange rate effects on cash and cash equivalents	—		—		—		(9	)	—		(9	)	—		—		—		(5	)	—		(5	)
Net increase (decrease) in cash and cash equivalents	—		—		57		1		—		58		—		—		12		64		—		76
Cash and cash equivalents as of beginning of period	—		—		30		409		—		439		—		—		16		447		—		463
Cash and cash equivalents as of end of period	—		—		87		410		—		497		—		—		28		511		—		539

4540

Table of Contents

CELANESE CORPORATION AND SUBSIDIARIES

UNAUDITED INTERIM CONSOLIDATING STATEMENT OF CASH FLOWS


	Nine Months Ended September 30, 2018												Six Months Ended June 30, 2019
	Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated		Parent Guarantor		Issuer		Subsidiary Guarantors		Non- Guarantors		Eliminations		Consolidated
	(In $ millions)												(In $ millions)
Net cash provided by (used in) operating activities	459		567		224		1,015		(1,070	)	1,195		636		(31	)	1,052		635		(1,561	)	731
Investing Activities
Capital expenditures on property, plant and equipment	—		—		(163	)	(81	)	—		(244	)	—		—		(83	)	(61	)	—		(144	)
Acquisitions, net of cash acquired	—		—		(144	)	—		—		(144	)	—		—		(31	)	(60	)	—		(91	)
Proceeds from sale of businesses and assets, net	—		—		—		13		—		13
Return of capital from subsidiary	—		—		225		—		(225	)	—		—		—		7		—		(7	)	—
Contributions to subsidiary	—		—		(16	)	—		16		—
Intercompany loan receipts (disbursements)	—		(327	)	(12	)	(285	)	624		—		—		—		(653	)	—		653		—
Other, net	—		—		(7	)	(27	)	—		(34	)	—		—		2		(10	)	—		(8	)
Net cash provided by (used in) investing activities	—		(327	)	(117	)	(380	)	415		(409	)	—		—		(758	)	(131	)	646		(243	)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less	—		(33	)	11		(52	)	(12	)	(86	)	—		149		3		(4	)	(43	)	105
Proceeds from short-term borrowings	—		—		—		44		—		44		—		—		—		610		(610	)	—
Repayments of short-term borrowings	—		—		—		(62	)	—		(62	)	—		—		—		(12	)	—		(12	)
Proceeds from long-term debt	—		285		327		—		(612	)	—		—		499		—		—		—		499
Repayments of long-term debt	—		(19	)	(13	)	(24	)	—		(56	)	—		(335	)	(1	)	(12	)	—		(348	)
Purchases of treasury stock, including related fees	(250	)	—		—		—		—		(250	)	(488	)	—		—		—		—		(488	)
Dividends to parent	—		(459	)	(611	)	—		1,070		—		—		(272	)	(251	)	(1,038	)	1,561		—
Contributions from parent	—		—		—		16		(16	)	—
Common stock dividends	(209	)	—		—		—		—		(209	)	(148	)	—		—		—		—		(148	)
Return of capital to parent	—		—		—		(225	)	225		—		—		—		—		(7	)	7		—
(Distributions to) contributions from noncontrolling interests	—		—		—		(14	)	—		(14	)
Distributions to noncontrolling interests													—		—		—		(7	)	—		(7	)
Other, net	—		—		(5	)	(1	)	—		(6	)	—		(10	)	(24	)	(4	)	—		(38	)
Net cash provided by (used in) financing activities	(459	)	(226	)	(291	)	(318	)	655		(639	)	(636	)	31		(273	)	(474	)	915		(437	)
Exchange rate effects on cash and cash equivalents	—		—		—		(20	)	—		(20	)	—		—		—		1		—		1
Net increase (decrease) in cash and cash equivalents	—		14		(184	)	297		—		127		—		—		21		31		—		52
Cash and cash equivalents as of beginning of period	—		—		230		346		—		576		—		—		30		409		—		439
Cash and cash equivalents as of end of period	—		14		46		643		—		703		—		—		51		440		—		491

4641

Table of Contents

21. Subsequent Events

Accounts Receivable Securitization

On July 6, 2020, the Company entered into an amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its US accounts receivable securitization facility among Celanese International Corporation, as servicer, certain of the Company's domestic subsidiaries, the Company's SPE, PNC Bank, National Association ("PNC Bank") and SMBC, as the Purchasers, and PNC Bank as administrator. The Amended Receivables Purchase Agreement extends the term of the securitization facility such that the SPE may sell certain receivables and request letters of credit until July 2, 2021 or upon a termination event, and contains certain representations, warranties and covenants. Under the Amended Receivables Purchase Agreement, transfers of US accounts receivable from the subsidiaries to the SPE are treated as sales and are accounted for as reductions in Trade receivables because the agreement transfers effective control over and risk related to the US accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred US accounts receivable, other than collection and administrative responsibilities and, once sold, the US accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. As a result, on July 6, 2020, the Company sold $87 million of its US accounts receivable to the Purchasers and repaid $87 million of borrowings from the US accounts receivable securitization facility. These sales were transacted at 100% of the face value of the relevant US accounts receivable, resulting in derecognition of the US accounts receivables from the Company's unaudited consolidated balance sheet. Unsold US accounts receivable of $30 million were pledged by the SPE as collateral to the Purchasers.

Sale of Polyplastics Co., Ltd. Joint Venture Equity Interest

On July 20, 2020, Celanese and a certain subsidiary entered into a definitive agreement to sell its 45% joint venture equity interest in its strategic affiliate, Polyplastics Co., Ltd. ("Polyplastics"), to its joint venture partner Daicel Corporation ("Daicel"), for a purchase price of approximately $1.6 billion in cash.

In addition to the sale of the Company's 45% equity interest in Polyplastics, the agreement provides for the amendment of certain supply agreements and the execution of certain intellectual property licenses between Celanese, certain of its affiliates and Polyplastics and Daicel, as applicable, as well as the termination of certain agreements and a mutual release of liabilities under such terminated agreements.

The transaction is currently expected to close in the second half of 2020, subject to possible extension. Consummation of the transaction is subject to customary closing conditions, including, among others, receipt of certain antitrust approvals, accuracy of representations and warranties, and performance by the parties of their respective covenants. Until the closing, Polyplastics will continue to operate under its current joint venture ownership structure and will continue to pay dividends in accordance with the existing joint venture agreements. Equity investment in earnings and dividends from Polyplastics are included in the Company's Engineered Materials segment.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese US" refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.

The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, ~~2018~~2019 filed on February ~~7, 2019~~6, 2020 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Reporting on Form 10-K ("~~2018~~2019 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP").

Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our ~~2018~~2019 Form 10-K.

Forward-Looking Statements

Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.

COVID-19 Update

On March 11, 2020, the World Health Organization declared the outbreak of a novel coronavirus ("COVID-19") as a pandemic, which originated in China and has spread throughout the world to substantially all locations where we have offices, production facilities, customers and suppliers, creating a dynamic and challenging situation worldwide. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home restrictions, travel restrictions and other public health safety measures.

Our employees' health and well-being continue to be of vital importance. We have implemented contingency planning, and employees who can work remotely are doing so from their homes to a significant extent. For employees who are considered essential and are working in plants, we have implemented government recommended protocols and best practices related to social distancing and best hygiene practices, including the use of additional personal protective equipment and enhanced cleaning protocols, where appropriate. We have also restricted visitor access and non-essential business travel. We have a global crisis team in place monitoring the evolving situation and recommending risk mitigation actions, including workplace health and safety measures. We also have site activation teams at all locations to guide and implement our careful return-to-office efforts in accordance with government regulations and recommended protocols. Our presence in China provided us with an advance view of how COVID-19 scenarios can unfold as well as the importance of taking early action.

We operate within a geographically-balanced global footprint and have the ability to utilize different production and distribution strategies depending on the business and product to satisfy customer demands. We continue to pursue our existing operational strategy. Since our industry is considered essential by the local governments in the majority of the areas we operate, most of our plants continue to be operational, and we have been able to maintain a largely consistent supply chain. However, as customer demand has weakened, we have temporarily reduced run rates at, and in some instances temporarily idled, certain of our plants to reduce costs and inventory levels. During the three and six months ended June 30, 2020, the effects of COVID-19 and related actions to control its spread had a significant, negative impact on the operating results of our Engineered Materials and Acetyl Chain segments, as discussed in more detail in the individual reporting segment sections below. We expect the

Table of Contents

declines in consumer demand, particularly in the Western Hemisphere, to continue to work through the relevant value chains through the second half of 2020. In Engineered Materials, our most impacted end markets reflect a significant decrease in big-ticket discretionary spending among consumers for items such as automobiles, electronics and appliances, as well as reduced spending on materials for industrial and construction applications and in medical applications, due to the delay in elective surgeries. Other application areas including food and beverage, pharma and 5G infrastructure are more resilient. In the Acetyl Chain, we benefit from a highly diversified set of end-uses with less exposure, relative to others in the industry, to end markets that have been most acutely impacted by COVID-19, like automotive. However, the historically low acetic acid pricing, along with the recent developments with global oil markets, continue to present a deflationary environment for the Acetyl Chain business. At the same time, we see resiliency and even growth in some applications within all of our segments, including packaging, hygiene products, disinfectants, pharma and cigarettes. We anticipate that our operations will continue to be negatively impacted on a short-term basis. We currently anticipate that customer demand and our results of operations should begin to normalize in 2021, absent a similar resurgence of COVID-19 and as the economies in which we operate begin to recover.

We have taken, and will continue to take, actions to mitigate the impact of COVID-19 on our results of operations, financial condition and cash flow. Through the capacity reductions we have implemented at our plants, we are managing inventory levels, reducing our manufacturing costs and optimizing our working capital. We have reduced discretionary spending such as travel and other corporate functional expenses. Although significant layoffs have not occurred within the Company during the three and six months ended June 30, 2020, some positions have been eliminated under a global restructuring program implemented largely as a result of cost cutting initiatives due to the current global economic environment. We have also engaged in temporary, targeted furloughs where plant operations have been reduced.

We are actively managing our business to maintain cash flow, and we believe that liquidity from (i) cash generated from operations; (ii) cash on hand; (iii) dividends from our portfolio of strategic investments; and (iv) cash available from our senior unsecured revolving credit facility and our accounts receivable securitization facility, will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future. We remain in compliance with the financial covenants under our senior unsecured revolving credit facility and short-term bilateral term loans and expect to remain in compliance based on our current expectation of future results of operations.

To preserve our cash balances and maintain liquidity, we have reduced our capital expenditures forecast from $500 million to less than $350 million for the full year 2020, prioritizing those projects that continue to drive productivity for us in the near-term. We remain fully committed to our current cash dividend. During the three months ended June 30, 2020, we temporarily paused share repurchases and will maintain current liquidity levels before deploying any discretionary operating cash flow for such share repurchases.

The extent to which COVID-19 will adversely impact our business, financial condition and results of operations will depend on numerous evolving factors, which are highly uncertain, rapidly changing and cannot be predicted. For further information regarding the impact COVID-19 could have on our business, financial condition and results of operations, see Part II - Item 1A. Risk Factors. For further discussion of our liquidity condition, see Liquidity and Capital Resources in this Part I - Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Risk Factors

See Part I - Item 1A. Risk Factors of our ~~2018~~2019 Form 10-K and subsequent periodic filings we make with the SEC for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements. These factors include, among other things:

changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;

the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;

changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;

the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases;

the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance;

Table of Contents

the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants;

increased price competition and the introduction of competing products by other companies;

the ability to identify desirable potential acquisition targets and to consummate acquisition or investment transactions, including obtaining regulatory approvals, consistent with our strategy;

~~Table of Contents~~

market acceptance of our technology;

the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us;

changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations that may impact recorded or future tax impacts associated with the Tax Cuts and Jobs Act (the "TCJA");

changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;

compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 outbreak), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather, natural disasters, or ~~natural disasters;~~other crises including public health crises;

potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change;

potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate;

changes in currency exchange rates and interest rates;

our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and

various other factors, both referenced and not referenced in this Quarterly Report.

Many of these factors are macroeconomic in nature and are, therefore, beyond our control. In addition, COVID-19 and responses to the pandemic by governments and businesses, have significantly increased financial and economic volatility and uncertainty, exacerbating the risks and potential impact of these factors. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates.

Overview

We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.

Our large and diverse global customer base primarily consists of major companies inacross a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track

Table of Contents

record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions.

~~Table of Contents~~

Results of Operations

Financial Highlights


	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended June 30,						Six Months Ended June 30,
	2019		2018		Change		2019		2018		Change		2020		2019		Change		2020		2019		Change
	(unaudited)												(unaudited)
	(In $ millions, except percentages)												(In $ millions, except percentages)
Statement of Operations Data
Net sales	1,586		1,771		(185	)	4,865		5,466		(601	)	1,193		1,592		(399	)	2,653		3,279		(626	)
Gross profit	414		516		(102	)	1,290		1,552		(262	)	242		423		(181	)	590		876		(286	)
Selling, general and administrative ("SG&A") expenses	(120	)	(129	)	9		(358	)	(412	)	54		(114	)	(118	)	4		(239	)	(238	)	(1	)
Other (charges) gains, net	(7	)	12		(19	)	(101	)	9		(110	)	(21	)	(98	)	77		(27	)	(94	)	67
Operating profit (loss)	260		374		(114	)	766		1,075		(309	)	83		186		(103	)	277		506		(229	)
Equity in net earnings (loss) of affiliates	45		66		(21	)	134		180		(46	)	31		39		(8	)	88		89		(1	)
Non-operating pension and other postretirement employee benefit (expense) income	17		25		(8	)	51		77		(26	)	27		17		10		55		34		21
Interest expense	(27	)	(30	)	3		(87	)	(95	)	8		(27	)	(29	)	2		(55	)	(60	)	5
Refinancing expense	—		—		—		(4	)	—		(4	)
Dividend income - equity investments	27		26		1		89		92		(3	)	32		30		2		69		62		7
Earnings (loss) from continuing operations before tax	323		462		(139	)	947		1,336		(389	)	147		239		(92	)	439		624		(185	)
Earnings (loss) from continuing operations	270		408		(138	)	820		1,120		(300	)	112		211		(99	)	339		550		(211	)
Earnings (loss) from discontinued operations	(5	)	(6	)	1		(7	)	(8	)	1		(3	)	(1	)	(2	)	(10	)	(2	)	(8	)
Net earnings (loss)	265		402		(137	)	813		1,112		(299	)	109		210		(101	)	329		548		(219	)
Net earnings (loss) attributable to Celanese Corporation	263		401		(138	)	809		1,108		(299	)	107		209		(102	)	325		546		(221	)
Other Data
Depreciation and amortization	94		90		4		261		255		6		87		84		3		172		167		5
SG&A expenses as a percentage of Net sales	7.6	%	7.3	%			7.4	%	7.5	%			9.6	%	7.4	%			9.0	%	7.3	%
Operating margin⁽¹⁾	16.4	%	21.1	%			15.7	%	19.7	%			7.0	%	11.7	%			10.4	%	15.4	%
Other (charges) gains, net
Restructuring	(6	)	(1	)	(5	)	(20	)	(4	)	(16	)	(2	)	(15	)	13		(8	)	(14	)	6
Asset impairments	—		—		—		(83	)	—		(83	)	(25	)	(83	)	58		(29	)	(83	)	54
Plant/office closures	(1	)	13		(14	)	(2	)	13		(15	)	6		—		6		5		(1	)	6
Commercial disputes	—		—		—		4		—		4		1		—		1		6		4		2
European Commission investigation													(2	)	—		(2	)	(2	)	—		(2	)
Other													1		—		1		1		—		1
Total Other (charges) gains, net	(7	)	12		(19	)	(101	)	9		(110	)	(21	)	(98	)	77		(27	)	(94	)	67

______________________________


⁽¹⁾	Defined as Operating profit (loss) divided by Net sales.

4946

Table of Contents


	As of September 30, 2019	As of December 31, 2018	As of June 30, 2020	As of December 31, 2019
	(unaudited)		(unaudited)
	(In $ millions)		(In $ millions)
Balance Sheet Data
Cash and cash equivalents	497	439	539	463

Short-term borrowings and current installments of long-term debt - third party and affiliates	368	561	1,045	496
Long-term debt, net of unamortized deferred financing costs	3,359	2,970	2,989	3,409
Total debt	3,727	3,531	4,034	3,905

Factors Affecting Business Segment Net Sales

The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows:

Three Months Ended ~~September~~June 30, ~~2019~~2020 Compared to Three Months Ended ~~September~~June 30, ~~2018~~2019


	Volume		Price		Currency		Other	Total		Volume		Price		Currency		Other	Total
	(unaudited)									(unaudited)
	(In percentages)									(In percentages)
Engineered Materials	(4	)	(2	)	(2	)	—	(8	)	(27	)	(1	)	(1	)	—	(29	)
Acetate Tow	—		—		—		—	—		(18	)	(5	)	—		—	(23	)
Acetyl Chain	6		(18	)	(2	)	—	(14	)	(14	)	(8	)	(1	)	—	(23	)
Total Company	2		(11	)	(2	)	1	(10	)	(20	)	(5	)	(1	)	1	(25	)

~~Nine~~Six Months Ended ~~September~~June 30, ~~2019~~2020 Compared to ~~Nine~~Six Months Ended ~~September~~June 30, ~~2018~~2019


	Volume		Price		Currency		Other	Total		Volume		Price		Currency		Other	Total
	(unaudited)									(unaudited)
	(In percentages)									(In percentages)
Engineered Materials	(5	)	2		(3	)	—	(6	)	(18	)	(3	)	(1	)	—	(22	)
Acetate Tow	—		—		—		—	—		(17	)	(5	)	—		—	(22	)
Acetyl Chain	—		(13	)	(3	)	—	(16	)	(9	)	(8	)	(1	)	1	(17	)
Total Company	(2	)	(6	)	(3	)	—	(11	)	(13	)	(6	)	(1	)	1	(19	)

Consolidated Results

Three Months Ended ~~September~~June 30, ~~2019~~2020 Compared to Three Months Ended ~~September~~June 30, ~~2018~~2019

Net sales decreased ~~$185~~$399 million, or ~~10%~~25%, for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower ~~pricing in~~volume across all of our ~~Acetyl Chain and Engineered Materials segments;~~

~~an unfavorable currency impact in our Acetyl Chain and Engineered Materials segments; and~~

~~lower volume in~~segments, primarily driven by our Engineered Materials ~~segment, primarily~~and Acetyl Chain segments due to ~~slower~~a continued deterioration of global economic conditions and ~~customer destocking;~~

~~partially offset by:~~

~~higher volume in our Acetyl Chain segment, primarily for VAM due to expansion~~global reduction in the ~~western hemisphere.~~customer demand environment as a result of the COVID-19 pandemic; and

lower pricing across all of our segments.

Operating profit decreased $103 million, or 55%, for the three months ended June 30, 2020 compared to the same period in 2019, primarily due to:

lower Net sales across all of our segments;

5047

Table of Contents

~~Operating profit decreased $114 million, or 30%, for the three months ended September 30, 2019 compared to the same period in 2018, primarily due to:~~

~~lower Net sales in our Acetyl Chain and Engineered Materials segments; and~~partially offset by:

•

~~an unfavorable~~a favorable impact to Other (charges) ~~gains.~~gains, net. During the three months ended ~~September~~June 30, ~~2018,~~2019, we ~~received a $13~~recorded an $83 million ~~non-income tax receivable refund from Nanjing, China,~~long-lived asset impairment loss related to the closure of our acetate flake manufacturing operations in Ocotlán, Mexico, which did not recur in the current year. See Note 1412 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information; and

~~partially offset by:~~

lower raw material costs within our Acetyl Chain and Engineered Materials segments.

On September 21, 2019, a localized fire occurred at our Clear Lake, Texas facility, resulting in damage to the carbon monoxide production unit, for which we recorded accelerated depreciation expense and clean-up costs of approximately $6 million during the three months ended September 30, 2019. We expect the financial impact on operating profit during the fourth quarter of 2019, excluding lost sales opportunities, to be approximately $35 million to $45 million, primarily related to certain fixed overhead, clean-up and repair costs.

Equity in net earnings (loss) of affiliates decreased ~~$21~~$8 million for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

a decrease in equity investment in earnings of ~~$21~~$6 million from our Ibn Sina strategic affiliate, primarily as a result of ~~plant turnaround activity.~~continued deterioration of global economic conditions.

Our effective income tax rate for the three months ended ~~September~~June 30, ~~2019~~2020 was ~~16%~~24% compared to 12% for the same period in ~~2018.~~2019. The higher effective income tax rate for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018~~2019 was primarily due to adjustments to the recorded impacts of certain uncertain tax positions due to available tax attribute carryforwards and the increased tax rate impact of ~~functional currency differences in offshore jurisdictions, partially offset by the release of the valuation allowance on foreign tax credit carryforwards~~such items due to ~~a change~~lower earnings in the ~~sourcing of US earnings between domestic and foreign sources.~~

current year due to the COVID-19 pandemic. See Note 1513 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

~~Nine~~Six Months Ended ~~September~~June 30, ~~2019~~2020 Compared to ~~Nine~~Six Months Ended ~~September~~June 30, ~~2018~~2019

Net sales decreased ~~$601~~$626 million, or ~~11%~~19%, for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower ~~pricing in~~volume across all of our ~~Acetyl Chain segment;~~

~~lower volume in our Engineered Materials segment,~~segments, primarily due to ~~slower~~a continued deterioration of global economic conditions and global reduction in the customer ~~destocking;~~demand environment as a result of the COVID-19 pandemic; and

~~an unfavorable currency impact within~~lower pricing across all of our ~~Acetyl Chain and Engineered Materials segments;~~

~~partially offset by:~~

~~higher pricing in our Engineered Materials segment.~~segments.

Operating profit decreased ~~$309~~$229 million, or ~~29%~~45%, for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower Net sales across all of our segments; and

higher plant turnaround and spending costs in our Engineered Materials and Acetyl Chain segments;

partially offset by:

lower raw material costs within our Acetyl Chain and Engineered Materials segments; and

•

~~an unfavorable~~a favorable impact to Other (charges) gains, net. During the ~~nine~~six months ended ~~September~~June 30, 2019, we recorded an $83 million long-lived asset impairment loss ~~in our Acetate Tow segment~~ related to the closure of our acetate flake manufacturing operations in Ocotlán, Mexico, ~~and $20 million~~which did not recur in ~~employee termination benefits, primarily related to business optimization projects.~~the current year. See Note 1412 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further ~~information;~~information.

Our effective income tax rate for the six months ended June 30, 2020 was 23% compared to 12% for the same period in 2019. The higher effective income tax rate for the six months ended June 30, 2020 compared to the same period in 2019 was primarily due to adjustments to the recorded impacts of certain uncertain tax positions due to available tax attribute carryforwards, the impact of functional currency differences in offshore jurisdictions and the increased tax rate impact of such items due to lower earnings in the current year due to the COVID-19 pandemic. See Note 13 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

5148

Table of Contents

~~partially offset by:~~

~~lower raw material costs within our Acetyl Chain segment; and~~

~~lower incentive compensation costs and project spending within Other Activities.~~

~~Equity in net earnings (loss) of affiliates decreased $46 million for the nine months ended September 30, 2019 compared to the same period in 2018, primarily due to:~~

~~a decrease in equity investment in earnings of $32 million from our Ibn Sina strategic affiliate, primarily as a result of plant turnaround activity; and~~

~~a decrease in equity investment in earnings of $13 million from our Polyplastics Co., Ltd. ("Polyplastics") strategic affiliate as a result of softer market conditions in China.~~

Our effective income tax rate for the nine months ended September 30, 2019 was 13% compared to 16% for the same period in 2018. The lower effective income tax rate for the nine months ended September 30, 2019 compared to the same period in 2018 was primarily due to 2019 reductions in the valuation allowance on foreign tax credits that resulted from greater forecasted utilization of credits prior to the expiration of their carryforward period.

Business Segments

Engineered Materials


	Three Months Ended September 30,				Change			% Change		Nine Months Ended September 30,				Change		% Change		Three Months Ended June 30,						Change		% Change			Six Months Ended June 30,					Change		% Change
	2019		2018				2019			2018			2020	Change		% Change		2019					2020			% Change		2019						Change		% Change
	(unaudited)																	(unaudited)
	(In $ millions, except percentages)																	(In $ millions, except percentages)
Net sales	591		642		Change		(51	% Change	)	(7.9	)%	1,847		1,971		(124	)		(6.3	)%	420			Change	593		(173	)		(29.2	)%		983		1,256		(273	)	(21.7	)%
Net Sales Variance
Volume	(4	)%								(5	)%							(27	)%										(18	)%
Price	(2	)%								2	%							(1	)%										(3	)%
Currency	(2	)%								(3	)%							(1	)%										(1	)%
Other	—	%								—	%							—	%										—	%
Other (charges) gains, net	(1	)	—		(1	)		(100.0	)%	6		—		6		100.0	%	(25	)		(8	)		(17	)	(212.5	)%		(25	)		7		(32	)	(457.1	)%
Operating profit (loss)	111		124		(13	)		(10.5	)%	358		365		(7	)	(1.9	)%	(13	)		103			(116	)	(112.6	)%		89			247		(158	)	(64.0	)%
Operating margin	18.8	%	19.3	%						19.4	%	18.5	%					(3.1	)%		17.4	%							9.1	%		19.7	%
Equity in net earnings (loss) of affiliates	41		62		(21	)		(33.9	)%	123		169		(46	)	(27.2	)%	26			36			(10	)	(27.8	)%		79			82		(3	)	(3.7	)%
Depreciation and amortization	33		31		2			6.5	%	96		96		—		—	%	32			31			1		3.2	%		66			63		3		4.8	%

Our Engineered Materials segment includes our engineered materials business, our food ingredients business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry. Our food ingredients business is a leading global supplier of acesulfame potassium for the food and beverage industry and is a leading producer of food protection ingredients, such as potassium sorbate and sorbic acid.

The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials. Therefore, in general, margins may expand or contract in response to changes in raw material costs.

~~Table of Contents~~

Three Months Ended ~~September~~June 30, ~~2019~~2020 Compared to Three Months Ended ~~September~~June 30, ~~2018~~2019

Net sales decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower volume ~~within~~for most of our ~~base business~~products driven by ~~slower~~a continued deterioration of global economic conditions ~~and customer destocking;~~as a result of the COVID-19 pandemic;

lower pricing for most of our products, primarily due to ~~reduced~~a continued reduction in customer demand, ~~in Asia,~~ as well as customer and product mix; and

an unfavorable currency impact resulting from a weaker Euro relative to the US dollar.

Operating profit decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower Net sales;

higher spending costs of $33 million, primarily as a result of plant turnaround activity and associated inventory costs; and

an unfavorable impact of $17 million to Other (charges) gains, net. During the three months ended June 30, 2020, we recorded a $25 million long-lived asset impairment loss related to certain fixed assets used in compounding operations at our facilities in Kaiserslautern, Germany; Wehr, Germany and Ferrara Marconi, Italy, partially offset by lower

Table of Contents

employee termination benefits related to business optimization projects in the current year. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information;

partially offset by:

lower raw material costs ~~primarily~~ for ~~methanol.~~most of our products.

Equity in net earnings (loss) of affiliates decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

~~Nine~~Six Months Ended ~~September~~June 30, ~~2019~~2020 Compared to ~~Nine~~Six Months Ended ~~September~~June 30, ~~2018~~2019

Net sales decreased for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower volume ~~within~~for most of our ~~base business~~products driven by ~~slower~~a continued deterioration of global economic conditions as a result of the COVID-19 pandemic;

lower pricing for most of our products, primarily due to a continued reduction in customer demand, as well as customer and ~~customer destocking;~~product mix; and

an unfavorable currency impact resulting from a weaker Euro relative to the US ~~dollar;~~

~~partially offset by:~~

~~higher pricing for certain products, primarily due to pricing efforts to align with rising raw material and distribution costs, as well as product mix.~~dollar.

Operating profit decreased for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

~~an unfavorable volume and currency impact within Net sales; and~~

~~higher raw material costs, primarily for polymers;~~

~~largely offset by:~~

~~a favorable pricing impact within~~lower Net sales;

~~lower energy~~higher spending costs of ~~$13~~$40 million, primarily ~~for steam;~~as a result of plant turnaround activity and associated inventory costs; and

•

~~a favorable~~an unfavorable impact of $6$32 million to Other (charges) gains, net. During the ~~nine~~six months ended ~~September~~June 30, 2020, we recorded a $25 million long-lived asset impairment loss related to certain fixed assets used in compounding operations at our facilities in Kaiserslautern, Germany; Wehr, Germany and Ferrara Marconi, Italy, partially offset by lower employee termination benefits related to business optimization projects in the current year. During the six months ended June 30, 2019, we also recorded a $15 million gain related to a settlement of a commercial dispute from a previous acquisition, ~~partially offset by $9 million~~which did not recur in ~~employee termination benefits, primarily related to business optimization projects.~~the current year. See Note 1412 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further ~~information.~~information;

partially offset by:

lower raw material costs for most of our products.

5350

Table of Contents

~~Equity in net earnings (loss) of affiliates decreased for the nine months ended September 30, 2019 compared to the same period in 2018, primarily due to:~~

~~a decrease in equity investment in earnings of $32 million from our Ibn Sina strategic affiliate, primarily as a result of plant turnaround activity; and~~

~~a decrease in equity investment in earnings of $13 million from our Polyplastics strategic affiliate as a result of softer market conditions in China.~~

Acetate Tow


	Three Months Ended September 30,				Change			% Change		Nine Months Ended September 30,				Change		% Change		Three Months Ended June 30,						Change		% Change			Six Months Ended June 30,					Change		% Change
	2019		2018				2019			2018			2020	Change		% Change		2019					2020			% Change		2019						Change		% Change
	(unaudited)																	(unaudited)
	(In $ millions, except percentages)																	(In $ millions, except percentages)
Net sales	158		158		Change		—	% Change		—	%	488		488		—			—	%	127			Change	164		(37	)		(22.6	)%		256		330		(74	)	(22.4	)%
Net Sales Variance
Volume	—	%								—	%							(18	)%										(17	)%
Price	—	%								—	%							(5	)%										(5	)%
Currency	—	%								—	%							—	%										—	%
Other	—	%								—	%							—	%										—	%
Other (charges) gains, net	(3	)	(1	)	(2	)		(200.0	)%	(87	)	(2	)	(85	)	(4,250.0	)%	—			(84	)		84		100.0	%		(1	)		(84	)	83		98.8	%
Operating profit (loss)	34		26		8			30.8	%	30		111		(81	)	(73.0	)%	31			(44	)		75		170.5	%		58			(4	)	62		1,550.0	%
Operating margin	21.5	%	16.5	%						6.1	%	22.7	%					24.4	%		(26.8	)%							22.7	%		(1.2	)%
Dividend income - equity investments	27		26		1			3.8	%	88		91		(3	)	(3.3	)%	32			29			3		10.3	%		69			61		8		13.1	%
Depreciation and amortization	14		21		(7	)		(33.3	)%	35		44		(9	)	(20.5	)%	9			11			(2	)	(18.2	)%		17			21		(4	)	(19.0	)%

Our Acetate Tow segment serves consumer-driven applications. We are a leading global producer and supplier of acetate tow and acetate flake, primarily used in filter products applications.

The pricing of products within the Acetate Tow segment is sensitive to demand and is primarily based on the value of the ~~material~~product we produce. Many sales in this business are conducted under contracts with pricing for one or more years. As a result, margins may expand or contract in response to changes in ~~raw material costs~~market conditions over these similar periods, and we may be unable to adjust pricing also due to other factors, such as the intense level of competition in the industry.

Three Months Ended ~~September~~June 30, ~~2019~~2020 Compared to Three Months Ended ~~September~~June 30, ~~2018~~2019

Net sales ~~remained flat~~decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018.~~2019, primarily due to:

lower acetate flake volume, primarily due to the expiration of an acetate flake contract;

lower acetate tow volume, consistent with global demand reduction; and

lower acetate tow pricing, primarily due to customer mix.

Operating profit increased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018, primarily due to:~~

~~higher accelerated depreciation and amortization expense of $7 million in 2018 related to the closure of our acetate tow manufacturing unit in Ocotlán, Mexico; and~~

~~lower energy costs of $6 million, primarily related to natural gas prices.~~

~~Nine Months Ended September 30,~~ 2019, ~~Compared to Nine Months Ended September 30, 2018~~

~~Net sales remained flat for the nine months ended September 30, 2019 compared to the same period in 2018.~~

~~Table of Contents~~

~~Operating profit decreased for the nine months ended September 30, 2019 compared to the same period in 2018,~~ primarily due to:

•

~~an unfavorable~~a favorable impact of ~~$85~~$84 million to Other (charges) gains, net. During the ~~nine~~three months ended ~~September~~June 30, 2019, we recorded an $83 million long-lived asset impairment loss related to the closure of our acetate flake manufacturing operations in Ocotlán, ~~Mexico. We expect to incur additional exit and shutdown costs related to Ocotlán,~~ Mexico, ~~of approximately $12 million through~~which did not recur in the ~~first quarter of 2020.~~current year. See Note 312 - ~~Acquisitions, Dispositions and Plant Closures~~Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information;

~~partially offset by:~~

~~higher accelerated depreciation and amortization expense of $8 million in 2018 related to the closure of our acetate tow manufacturing unit in Ocotlán, Mexico; and~~

lower energy costs of $8 million, primarily related to ~~natural gas prices.~~the closure of our acetate flake manufacturing unit in Ocotlán, Mexico in the prior year; and

lower spending of $5 million, primarily due to a reduction in operating costs as a result of the closure of our acetate flake manufacturing unit in Ocotlán, Mexico in the prior year;

partially offset by:

lower Net sales.

Table of Contents

Six Months Ended June 30, 2020 Compared to Six Months Ended June 30, 2019

Net sales decreased for the six months ended June 30, 2020 compared to the same period in 2019.

lower acetate flake volume, primarily due to the expiration of an acetate flake contract;

lower acetate tow volume, consistent with global demand reduction; and

lower acetate tow pricing, primarily due to customer mix.

Operating profit increased for the six months ended June 30, 2020 compared to the same period in 2019, primarily due to:

•

a favorable impact of $83 million to Other (charges) gains, net. During the six months ended June 30, 2019, we recorded an $83 million long-lived asset impairment loss related to the closure of our acetate flake manufacturing operations in Ocotlán, Mexico, which did not recur in the current year. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information;

lower energy costs of $15 million, primarily related to the closure of our acetate flake manufacturing unit in Ocotlán, Mexico in the prior year; and

lower spending of $4 million, primarily due to a reduction in operating costs due to the closure of our acetate flake manufacturing unit in Ocotlán, Mexico in the prior year;

partially offset by:

lower Net sales.

Dividend income from equity investments increased for the six months ended June 30, 2020 compared to the same period in 2019, primarily due to:

higher earnings from our acetate tow joint ventures related to the expiration of an acetate flake contract, which was assumed by Nantong Cellulose Fibers Co. Ltd.

Table of Contents

Acetyl Chain


	Three Months Ended September 30,				Change			% Change		Nine Months Ended September 30,				Change		% Change		Three Months Ended June 30,						Change		% Change			Six Months Ended June 30,					Change		% Change
	2019		2018				2019			2018			2020	Change		% Change		2019					2020			% Change		2019						Change		% Change
	(unaudited)																	(unaudited)
	(In $ millions, except percentages)																	(In $ millions, except percentages)
Net sales	867		1,006		Change		(139	% Change	)	(13.8	)%	2,621		3,106		(485	)		(15.6	)%	662			Change	865		(203	)		(23.5	)%		1,461		1,754		(293	)	(16.7	)%
Net Sales Variance
Volume	6	%								—	%							(14	)%										(9	)%
Price	(18	)%								(13	)%							(8	)%										(8	)%
Currency	(2	)%								(3	)%							(1	)%										(1	)%
Other	—	%								—	%							—	%										1	%
Other (charges) gains, net	—		12		(12	)		(100.0	)%	(1	)	10		(11	)	(110.0	)%	5			(1	)		6		600.0	%		5			(1	)	6		600.0	%
Operating profit (loss)	180		287		(107	)		(37.3	)%	570		813		(243	)	(29.9	)%	121			188			(67	)	(35.6	)%		256			390		(134	)	(34.4	)%
Operating margin	20.8	%	28.5	%						21.7	%	26.2	%					18.3	%		21.7	%							17.5	%		22.2	%
Depreciation and amortization	43		36		7			19.4	%	119		107		12		11.2	%	42			38			4		10.5	%		81			76		5		6.6	%

Our Acetyl Chain segment includes the integrated chain of our intermediate chemistry, emulsion polymers, ~~and~~ ethylene vinyl acetate ("EVA") polymers and redispersible powders businesses. Our intermediate chemistry business produces and supplies acetyl products, including acetic acid, vinyl acetate monomer ("VAM"), acetic anhydride and acetate esters. These products are generally used as starting materials for colorants, paints, adhesives, coatings and pharmaceuticals. It also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products. Our emulsion polymers business is a leading global producer of vinyl acetate-based emulsions and develops products and application technologies to improve performance, create value and drive innovation in applications such as paints and coatings, adhesives, construction, glass fiber, textiles and paper. Our EVA polymers business is a leading North American manufacturer of a full range of specialty EVA resins and compounds, as well as select grades of low-density polyethylene. Our EVA polymers products are used in many applications, including flexible packaging films, lamination film products, hot melt adhesives, automotive parts and carpeting. Our redispersible powders business produces polymer emulsions which are converted into powdered thermoplastic resin materials. Redispersible powders products are used in a variety of applications in the mortar industry, including decorative mortar, exterior insulation and finish systems, gypsum-based materials, plaster and render, self-leveling floor systems, skim coat and tile adhesives.

The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw material costs over months or quarters.

Three Months Ended ~~September~~June 30, ~~2019~~2020 Compared to Three Months Ended ~~September~~June 30, ~~2018~~2019

Net sales decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:


•	lower volume for most of our products due to a continued global reduction in the customer demand environment as a result of the COVID-19 pandemic, partially offset by higher volume for redispersible powders due to the acquisition of Nouryon's redispersible polymer powders business offered under the Elotex^® brand ("Elotex");

lower pricing for most of our products, primarily due to ~~reduced~~a continued global reduction in the customer demand ~~in Asia~~environment and an overall deflationary environment for raw ~~materials;~~materials as a result of the COVID-19 pandemic; and

~~Table of Contents~~

an unfavorable currency impact resulting from a weaker Euro relative to the US ~~dollar;~~

~~partially offset by:~~

~~higher volume, primarily for VAM due to expansion in the western hemisphere, which represents substantially all of the increase in volume.~~dollar.

Operating profit decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower Net sales; and

higher costs of $7 million, primarily related to our acquisition of Elotex;

Table of Contents

partially offset by:

lower raw material costs, primarily for ethylene, methanol and carbon monoxide, with ethylene making up approximately one-half of the decrease and methanol and carbon monoxide making up the remainder of the decrease in raw material costs;

lower energy costs of $10 million, primarily related to lower energy prices;

a favorable impact of $8 million, primarily related to productivity initiatives; and

•

~~an unfavorable~~a favorable impact of ~~$12~~$6 million to Other (charges) gains, net. During the three months ended ~~September~~June 30, ~~2018,~~2020, we received a ~~$13~~$6 million non-income tax ~~receivable refund~~credit from Nanjing, ~~China, which did not recur in the current year.~~China. See Note 1412 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further ~~information;~~information.

~~partially offset by:~~

~~lower raw material costs for methanol, ethylene and acetic acid, which combined represents approximately three-fourths of the decrease.~~

~~Nine~~Six Months Ended ~~September~~June 30, ~~2019~~2020 Compared to ~~Nine~~Six Months Ended ~~September~~June 30, ~~2018~~2019

Net sales decreased for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower volume for most of our products due to a continued global reduction in the customer demand environment as a result of the COVID-19 pandemic, partially offset by higher volume for redispersible powders due to our acquisition of Elotex;

an unfavorable currency impact resulting from a weaker Euro relative to the US dollar.

~~Volume was flat~~Operating profit decreased for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018 due to reduced customer demand for acetic acid in Asia, mostly offset by higher volume for VAM due to expansion in the western hemisphere.~~

~~Operating profit decreased for the nine months ended September 30,~~ 2019, ~~compared to the same period in 2018,~~ primarily due to:

lower Net sales;

higher plant turnaround costs of $17 million related to our joint venture, Fairway Methanol LLC ("Fairway"); and

higher costs of $13 million, primarily related to our acquisition of Elotex;

partially offset by:

lower raw material costs for ethylene, methanol and carbon monoxide, with ethylene making up approximately one-half of the decrease and methanol and carbon monoxide making up the remainder of the decrease in raw material costs;

lower energy costs of $14 million, primarily related to lower energy prices; and

•

~~an unfavorable~~a favorable impact of ~~$11~~$6 million to Other (charges) gains, net. During the ~~nine~~six months ended ~~September~~June 30, ~~2018,~~2020, we received a ~~$13~~$6 million non-income tax ~~receivable refund~~credit from Nanjing, ~~China, which did not recur in the current year.~~China. See Note 1412 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further ~~information;~~information.

~~partially offset by:~~

~~lower raw material costs for methanol, ethylene and acetic acid, which combined represents approximately three-fourths of the decrease.~~

5654

Table of Contents

Other Activities


	Three Months Ended September 30,				Change			% Change		Nine Months Ended September 30,				Change		% Change		Three Months Ended June 30,						Change			% Change			Six Months Ended June 30,						Change			% Change
	2019		2018				2019			2018			2020	Change		% Change		2019					2020				% Change		2019							Change			% Change
	(unaudited)																	(unaudited)
	(In $ millions, except percentages)																	(In $ millions, except percentages)
Other (charges) gains, net	(3	)	1		Change		(4	% Change	)	(400.0	)%	(19	)	1		(20	)		(2,000.0	)%	(1	)		Change	(5	)		4			80.0	%		(6	)		(16	)		10	62.5	%
Operating profit (loss)	(65	)	(63	)	(2	)		(3.2	)%	(192	)	(214	)	22		10.3	%	(56	)		(61	)		5			8.2	%		(126	)		(127	)		1			0.8	%
Equity in net earnings (loss) of affiliates	3		2		1			50.0	%	8		6		2		33.3	%	5			2			3			150.0	%		8			5			3			60.0	%
Non-operating pension and other postretirement employee benefit (expense) income	17		25		(8	)		(32.0	)%	51		77		(26	)	(33.8	)%	27			17			10			58.8	%		55			34			21			61.8	%
Dividend income - equity investments	—		—		—			—	%	1		1		—		—	%	—			1			(1	)		(100.0	)%		—			1			(1	)		(100.0	)%
Depreciation and amortization	4		2		2			100.0	%	11		8		3		37.5	%	4			4			—			—	%		8			7			1			14.3	%

Other Activities primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments.

Three Months Ended ~~September~~June 30, ~~2019~~2020 Compared to Three Months Ended ~~September~~June 30, ~~2018~~2019

Operating loss ~~increased~~decreased for the three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

•

~~an unfavorable~~a favorable impact of $4 million to Other (charges) gains, ~~net. During the three months ended September 30, 2019 we recorded $3 million in~~net, primarily due to lower employee termination benefits ~~primarily~~ related to business optimization ~~projects.~~projects in the current year. See Note ~~14 - Other (Charges) Gains, Net~~ ~~in the accompanying unaudited interim consolidated financial statements for further information; and~~

~~higher functional spending of $3 million;~~

~~partially offset by:~~

~~lower incentive compensation costs.~~

~~Non-operating pension and other postretirement employee benefit income decreased for the three months ended September 30, 2019 compared to the same period in 2018, primarily due to:~~

~~lower expected return on plan assets.~~

~~Nine Months Ended September 30, 2019 Compared to Nine Months Ended September 30, 2018~~

~~Operating loss decreased for the nine months ended September 30, 2019 compared to the same period in 2018, primarily due to:~~

~~lower incentive compensation costs and project spending of $37 million;~~

~~Table of Contents~~

~~partially offset by:~~

•

an unfavorable impact of $20 million to Other (charges) gains, net. During the nine months ended September 30, 2019 we recorded an $11 million loss related to a settlement by our captive insurer with a former third-party customer. In addition, during the nine months ended September 30, 2019 we recorded $8 million in employee termination benefits, primarily related to business optimization projects. See ~~Note 14~~12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information.

Non-operating pension and other postretirement employee benefit income ~~decreased~~increased for the ~~nine~~three months ended ~~September~~June 30, ~~2019~~2020 compared to the same period in ~~2018,~~2019, primarily due to:

lower interest cost and higher expected return on plan assets.

Six Months Ended June 30, 2020 Compared to Six Months Ended June 30, 2019

Operating loss decreased for the six months ended June 30, 2020 compared to the same period in 2019, primarily due to:

•

a favorable impact of $10 million to Other (charges) gains, net. During the six months ended June 30, 2019, we recorded an $11 million loss related to a settlement by our captive insurer with a former third-party customer, which did not recur in the current year. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information;

partially offset by:

an unfavorable currency impact of $6 million resulting from a weaker Euro relative to the US dollar.

Non-operating pension and other postretirement employee benefit income increased for the six months ended June 30, 2020 compared to the same period in 2019, primarily due to:

lower interest cost and higher expected return on plan assets.

5855

Table of Contents

Liquidity and Capital Resources

Our primary source of liquidity is cash generated from operations, available cash and cash equivalents and dividends from our portfolio of strategic investments. In addition, as of ~~September~~June 30, ~~2019,~~2020, we have $1.1 billion available for borrowing under our senior unsecured revolving credit facility and $5 million available under our accounts receivable securitization facility to assist, if required, in meeting our working capital needs and other contractual obligations.

While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.

Total cash outflows for capital expenditures are expected to be in the range of ~~$375~~$325 million to ~~$400~~$350 million in ~~2019,~~2020, primarily due to additional investments in growth opportunities and productivity improvements primarily in our Engineered Materials and Acetyl Chain segments.

On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese US, have no material assets other than the stock of their subsidiaries and no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese US in order to meet their obligations, including their obligations under senior credit facilities and senior notes, and to pay dividends on our Common stock, par value $0.0001 per share ("Common Stock").

We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, India and Indonesia. Capital controls impose limitations on our ability to exchange currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling.

We remain in compliance with the financial covenants under our senior unsecured revolving credit facility and short-term bilateral term loans and expect to remain in compliance based on our current expectation of future results of operations. If our actual future results of operations differ materially from these expectations, including if a material and prolonged economic downturn results in increased indebtedness or substantially lower EBITDA, we may be required to seek an amendment or waiver of such covenant which may increase our borrowing costs under those debt instruments.

Cash Flows

Cash and cash equivalents increased ~~$58~~$76 million to ~~$497~~$539 million as of ~~September~~June 30, ~~2019~~2020 compared to December 31, ~~2018.~~2019. As of ~~September~~June 30, ~~2019, $348~~2020, $478 million of the ~~$497~~$539 million of cash and cash equivalents was held by our foreign subsidiaries. ~~These funds are largely accessible, if needed in the US to fund operations.~~ Under the TCJA, we have incurred a prior year charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash. These funds are largely accessible without additional material tax consequences, if needed in the US, to fund operations. See Note 1513 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

Net Cash Provided by (Used in) Operating Activities

Net cash provided by operating activities decreased ~~$67~~$93 million to ~~$1.1 billion~~$638 million for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to ~~$1.2 billion~~$731 million for the same period in ~~2018.~~2019. Net cash provided by operating activities for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 decreased, primarily due to:

a decrease in net earnings;

~~largely~~partially offset by:

~~favorable trade working capital of $257 million, primarily due to~~ a decrease in ~~inventory~~cash taxes paid of $56 million; and ~~trade receivables. Inventory decreased as~~

a ~~result~~decrease in incentive compensation payouts of ~~inventory build-up for plant turnarounds which occurred in the prior year and lower costs for raw materials in the current year. Trade receivables decreased due to timing~~$50 million.

Table of ~~collections.~~Contents

Net Cash Provided by (Used in) Investing Activities

Net cash used in investing activities ~~decreased $84~~increased $66 million to ~~$325~~$309 million for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to ~~$409~~$243 million for the same period in ~~2018,~~2019, primarily due to:

~~a net cash outflow~~an increase of ~~$144~~$63 million in capital expenditures related to ~~the acquisition of Omni Plastics, L.L.C.~~growth and ~~its subsidiaries~~productivity improvements in ~~February 2018, which did not recur this year;~~our Engineered Materials and

~~Table of Contents~~

~~higher capital expenditures during the nine months ended September 30, 2018, primarily due to plant expansions within our~~ Acetyl Chain ~~segment in the prior year;~~

~~partially offset by:~~

~~a net cash outflow of $91 million, primarily related to the acquisition of Next Polymers Ltd. in January 2019.~~segments.

Net Cash Provided by (Used in) Financing Activities

Net cash used in financing activities ~~increased $97~~decreased $189 million to ~~$736~~$248 million for the ~~nine~~six months ended ~~September~~June 30, ~~2019~~2020 compared to ~~$639~~$437 million for the same period in ~~2018,~~2019, primarily due to:

~~an increase of $513 million in~~lower share repurchases of our Common Stock of $321 million during the ~~nine~~six months ended ~~September~~June 30, ~~2019;~~2020; and


•	~~an increase in cash dividends on our Common Stock of~~ ~~$16 million. During the nine months ended September 30, 2019, we increased our quarterly cash dividend rate from $0.54 to $0.62 per share;~~

~~partially offset by:~~

an increase in net borrowings on short-term debt of ~~$256~~$27 million, due to higher borrowings during the six months ended June 30, 2020 related to us entering into an aggregate of $300 million in short-term, bilateral term loans, which were primarily ~~as a result of higher~~used to repay borrowings under our outstanding senior unsecured revolving credit ~~facility during the nine months ended September 30, 2019 related to the timing of share repurchases of our Common Stock; and~~facility;

~~an increase~~partially offset by:

a decrease in net proceeds from long-term debt of ~~$201~~$167 million, primarily due to the issuance of $500 million in principal amount of the 3.500% senior unsecured notes due May 8, 2024, ~~(the "3.500% Notes"),~~ partially offset by the redemption of the 3.250% senior unsecured notes, ~~(the "3.250% Notes")~~ during the ~~nine~~six months ended ~~September~~June 30, 2019, ~~as discussed below.~~which did not recur in the current year.

Debt and Other Obligations

On May 8, 2019, Celanese US completed an offering of $500 million in principal amount of the 3.500% Notes in a public offering registered under the Securities Act. The 3.500% Notes were issued at a discount to par at a price of 99.895%, which is being amortized to Interest expense in the unaudited interim consolidated statement of operations over the term of the 3.500% Notes. Net proceeds from the sale of the 3.500% Notes were used to redeem in full the 3.250% Notes, to repay $156 million of outstanding borrowings under the senior unsecured revolving credit facility and for general corporate purposes. In connection with the issuance of the 3.500% Notes, we entered into a cross-currency swap to effectively convert our fixed-rate US dollar denominated debt under the 3.500% Notes, including annual interest payments and the payment of principal at maturity, to fixed-rate Euro denominated debt.

On January 7, 2019, Celanese, Celanese US and certain subsidiary borrowers entered into a new senior credit agreement (the "Credit Agreement") consisting of a $1.25 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2024. The Credit Agreement is guaranteed by Celanese, Celanese US and substantially all of its domestic subsidiaries.

There have been no material changes to our debt or other obligations described in our ~~2018~~2019 Form 10-K other than those disclosed above and in Note 108 - Debt in the accompanying unaudited interim consolidated financial statements.

Other Financing Arrangements

~~Our US accounts receivable securitization facility was amended on July 8, 2019 to extend the maturity date to July 6, 2020.~~

~~Table of Contents~~

~~In June 2018, we entered into~~We have a factoring agreement with a global financial institution to sell certain accounts receivable on a non-recourse basis. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the receivables to the buyer. We have no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. We de-recognized ~~$196~~$110 million and ~~$117~~$257 million of accounts receivable as of ~~September~~June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, respectively.

See Note 21 - Subsequent Events in the accompanying unaudited interim consolidated financial statements.

Share Capital

On July 15, 2020, our Board of Directors approved a $500 million increase in our Common Stock repurchase authorization. As of June 30, 2020, we had $1.1 billion remaining under the previous authorization. We also declared a quarterly cash dividend of $0.62 per share on our Common Stock on ~~October 16, 2019,~~July 15, 2020, amounting to ~~$75~~$73 million. ~~The cash dividend will be paid on November 7, 2019 to holders of record as of October 28, 2019.~~

There have been no material changes to our share capital described in our ~~2018~~2019 Form 10-K other than those disclosed above and in Note 1311 - Stockholders' Equity in the accompanying unaudited interim consolidated financial statements.

Contractual Obligations

Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our ~~2018~~2019 Form 10-K.

Table of Contents

Sale of Polyplastics Co., Ltd. Joint Venture Equity Interest

On July 20, 2020, we entered into a definitive agreement to sell our 45% joint venture equity interest in our strategic affiliate, Polyplastics Co., Ltd., to our joint venture partner, Daicel Corporation, for a purchase price of approximately $1.6 billion in cash. See Note 21 - Subsequent Events in the accompanying unaudited interim consolidated financial statements.

Off-Balance Sheet Arrangements

We have not entered into any material off-balance sheet arrangements.

Critical Accounting Policies and Estimates

Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.

We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our ~~2018~~2019 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our ~~2018~~2019 Form 10-K.

Recent Accounting Pronouncements

See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our ~~2018~~2019 Form 10-K. See also Note 1714 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations.

~~Table of Contents~~

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of ~~September~~June 30, ~~2019,~~2020, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.

Changes in Internal Control Over Financial Reporting

During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

6258

Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of its business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust and competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy stockholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where it is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss may not represent the ultimate loss to the Company from legal proceedings. See Note 1210 - Environmental and Note 1916 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for a discussion of material environmental matters and material commitments and contingencies related to legal and regulatory proceedings. There have been no significant developments in the "Legal Proceedings" described in our ~~2018~~2019 Form 10-K other than those disclosed in Note 1210 - Environmental and Note 1916 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements. See Part I - Item 1A. Risk Factors of our ~~2018~~2019 Form 10-K for certain risk factors relating to these legal proceedings.

Item 1A. Risk Factors

~~There have been no material changes to~~The Company is supplementing the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 6, 2020 (the "2019 Form 10-K"), to include the following risk factor under ~~Part I,~~the heading "Risks Related to Our Business."

The extent to which the novel coronavirus ("COVID-19") pandemic or similar public health crises will adversely impact our business, financial condition and results of operations remains highly uncertain and cannot be predicted.

Public health crises such as pandemics or similar outbreaks could adversely impact our business. In December 2019, a novel strain of a virus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), or coronavirus, which causes coronavirus disease 2019, or COVID-19, surfaced in Wuhan, China and has reached substantially all locations where we and our customers and suppliers have offices and production facilities. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home restrictions, travel restrictions and other public health safety measures, as well as reported adverse impacts on healthcare resources, facilities and providers. COVID-19 has significantly impacted our operations, and the extent to which COVID-19 continues to impact our operations or those of our customers or suppliers will depend on future developments and numerous factors, which are highly uncertain and cannot be predicted with confidence, including the duration and geographic spread of the outbreak, additional or modified government actions, new information that may emerge concerning the severity and impact of COVID-19 and the actions to contain COVID-19 or address its impact in the short and long term, among others.

the duration, scope, severity and geographic spread of the outbreak;

governmental, business and individual actions that have been and continue to be taken in response to the outbreak, including social distancing, work-at-home, stay-at-home and shelter-in-place orders and shutdowns, travel restrictions and quarantines;

the effect of the outbreak on our customers, suppliers, supply chain and other business partners;

our ability during the outbreak to provide our products and services, including the health and well-being of our employees;

business disruptions caused by actual or potential plant, workplace and office closures, and an increased reliance on employees working from home, disruptions to or delays in ongoing laboratory and product testing, experiments and operations, staffing shortages, travel limitations, employee health issues, cyber security and data accessibility, or communication or mass transit disruptions, any of which could adversely impact our business operations or delay necessary interactions with local regulators, manufacturing sites and other important agencies and contractors;

Table of Contents

the ability of our customers to pay for our products and services during and following the outbreak;

the impact of the outbreak on the financial markets and economic activity generally;

our ability to access usual sources of liquidity on reasonable terms; and

our ability to comply with the financial covenant in our Credit Agreement if a material and prolonged economic downturn results in increased indebtedness or substantially lower EBITDA.

The COVID-19 pandemic has significantly increased financial and economic volatility and uncertainty. The slowdown or downturn in the economy has had, and we expect will continue to have, a negative impact on many of our customers, as well as the end customers of products for which our products serve as materials and inputs. Our operations and financial results could be materially adversely impacted to the extent that the decline in certain customer orders continues or is materially greater than we have experienced to date during the COVID-19 pandemic or that we expect, or our expenses increase due to the impact of the pandemic, including as a result of impacts on our labor costs or productivity, supply chain disruptions or future actions by governments or businesses.

The COVID-19 pandemic continues to evolve, and it is unknown how long disruptions to our business operations resulting from the COVID-19 pandemic, including any disruptions relating to the ultimate geographic spread of the disease. However, any prolonging of the pandemic-related disruptions could have a material adverse impact on our business, financial condition and results of operations. We have monitored and will continue to monitor the situation closely.

In addition, the trading prices for our common stock and other chemical companies have been at certain times highly volatile as a result of the COVID-19 pandemic. If such volatility were to recur, we could face difficulties raising capital through equity or debt financings, or such financing transactions may be on unfavorable terms.

Please also refer to the complete Item 1A of ~~our~~ ~~2018~~the 2019 Form ~~10-K.~~10-K filed for additional risks and uncertainties facing the Company that may have a material adverse effect on the Company's business prospects, financial condition and results of operations. The COVID-19 pandemic, and responses to the pandemic by governments and businesses, have exacerbated many of the risks and potential impact of the factors addressed in Item 1A of the 2019 Form 10-K, and may affect us in additional ways or to an extent that we currently do not expect or consider to be significant.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of our Common Stock during the three months ended ~~September~~June 30, ~~2019~~2020 are as follows:

Period
Total Number
of Shares
Purchased⁽¹⁾

Average
Price Paid
per Share

Total Number of
Shares Purchased as
Part of Publicly
Announced Program

Approximate Dollar
Value of Shares
Remaining that may be
Purchased Under the Program⁽²⁾
(unaudited)
July 1-31, 2019 267,200
$ 112.25
267,200
$ 1,683,000,000
August 1-31, 2019 1,524,662
$ 108.22
1,524,662
$ 1,518,000,000
September 1-30, 2019 652,416
$ 122.64
652,416
$ 1,438,000,000
Total 2,444,278
2,444,278



Period	Total Number of Shares Purchased⁽¹⁾	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Program	Approximate Dollar Value of Shares Remaining that may be Purchased Under the Program⁽²⁾
	(unaudited)
April 1-30, 2020	—	$	—	—	$	1,063,000,000
May 1-31, 2020	—	$	—	—	$	1,063,000,000
June 1-30, 2020	—	$	—	—	$	1,063,000,000
Total	—			—

______________________________


⁽¹⁾	May include shares withheld from employees to cover their withholding requirements for personal income taxes related to the vesting of restricted stock.


⁽²⁾	As of ~~September~~June 30, ~~2019~~2020, our Board of Directors has authorized the repurchase of $5.4 billion of our Common Stock since February 2008. On July 15, 2020, the Board of Directors approved a $500 million increase in our Common Stock repurchase authorization.

See Note 1311 - Stockholders' Equity in the accompanying unaudited interim consolidated financial statements for further information.

Table of Contents

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

6361

Table of Contents

Item 6. Exhibits⁽¹⁾



Exhibit Number
Exhibit Number		Description

3.1		Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q filed with the SEC on October 18, 2016).

3.1(a)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Celanese Corporation dated as of April 21, 2016 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on April 22, 2016).

3.1(b)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Celanese Corporation dated as of September 17, 2018 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on September 17, 2018).

3.1(c)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Celanese Corporation dated April 18, 2019 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on April 23, 2019).

3.2		Sixth Amended and Restated By-laws, amended effective July 15, 2019 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on July 18, 2019).

10.210.1‡†		~~Offer Letter,~~Form of 2020 Time-Based Restricted Stock Unit Award Agreement (for non-employee directors).

10.2		Transaction Agreement, dated ~~April 5, 2019, between~~July 20, 2020, among Celanese Corporation, Celanese Sales Netherlands B.V., Daicel Corporation and ~~Lori Ryerkerk.~~Polyplastics Company Ltd. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on July 20, 2020).

31.1*		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH*		Inline XBRL Taxonomy Extension Schema Document.

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended ~~September~~June 30, ~~2019~~2020 has been formatted in Inline XBRL.


*	Filed herewith.


‡	Indicates a management contract or compensatory plan or arrangement.


†	This document was previously filed as the like-numbered exhibit to our Form 10-Q for the quarter ended June 30, 2019, filed with the SEC on July 23, 2019, and is being refiled to correct typographical errors in the version previously filed to conform to the executed version.

⁽¹⁾

The Company and its subsidiaries have in the past issued, and may in the future issue from time to time, long-term debt. The Company may not file with the applicable report copies of the instruments defining the rights of holders of long-term debt to the extent that the aggregate principal amount of the debt instruments of any one series of such debt instruments for which the instruments have not been filed has not exceeded or will not exceed 10% of the assets of the Company at any pertinent time. The Company hereby agrees to furnish a copy of any such instrument(s) to the SEC upon request.

6462

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



CELANESE CORPORATION

	By:	/s/ LORI J. RYERKERK
		Lori J. Ryerkerk
		Chairman of the Board of Directors,
		Chief Executive Officer and President

		Date:	~~October 22, 2019~~July 29, 2020



By:	/s/ SCOTT A. RICHARDSON
	Scott A. Richardson
	~~Senior~~Executive Vice President and
	Chief Financial Officer

	Date:	~~October 22, 2019~~July 29, 2020

6563



	Foreign Currency Translation Gain (Loss)		Gain (Loss) on Cash Flow Hedges (Note 17)		Pension and Postretirement Benefits Gain (Loss) (Note 11)		Accumulated Other Comprehensive Income (Loss), Net
	(In $ millions)
As of December 31, 2018	(236	)	(8	)	(3	)	(247	)
Other comprehensive income (loss) before reclassifications	(3	)	(50	)	—		(53	)
Amounts reclassified from accumulated other comprehensive income (loss)	—		(5	)	—		(5	)
Income tax (provision) benefit	(8	)	7		—		(1	)
As of September 30, 2019	(247	)	(56	)	(3	)	(306	)



	As of September 30, 2019
	Operating Leases		Finance Leases
	(In $ millions)
2019	10		11
2020	34		40
2021	26		39
2022	23		30
2023	20		22
Later years	146		86
Sublease income	—		—
Total lease payments	259		228
Less amounts representing interest	(46	)	(82	)
Total lease obligations	213		146



	As of December 31, 2018
	Operating Leases	Capital Leases
	(In $ millions)
2019	43	42
2020	34	42
2021	25	40
2022	23	32
2023	21	23
Later years	130	88
Sublease income	—	—
Minimum lease commitments	276	267
Less amounts representing interest		(100	)
Present value of net minimum lease obligations		167